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PREFACE 
For an understanding of the action of a drug in a living 
organism it is necessary to know the pharmacology, or what 
the drug does to the body but also the pharmacokinetics and 
the drug metabolism, or what the body does to the drug. 
Pharmacokinetics deals with the rate processes of absorption, 
distribution, metabolism and excretion of drugs and other 
chemical substances in the body of man and animals. 
Volatile or hydrophillc substances may be eliminated by 
expiration through the lungs or by excretion through the 
kidneys. However, many drugs are lipophylic, which implies 
that they leave the body with difficulty unless they are 
metabolized or conjugated to hydrophillc metabolites which 
in their turn are excreted with the bile and the urine. 
It is useful to characterize the drug elimination process 
(metabolism, excretion etc.) by a total clearance constant (in 
liters per hour or ml per minute). For lipophilic drugs the 
metabolic clearance by the liver is mainly responsible for the 
elimination clearance. 
The rate of elimination of a drug from the body also 
depends on the volume of distribution. In other words, the 
question is how large is the volume that is cleared at a 
certain rate. The volume of distribution depends on the 
binding of drugs to various tissues sothat one can study the 
metabolic clearance more exactly if one could follow the rate 
of metabolism in an isolated liver system. Experiments have 
therefore been conducted to study the kinetics of a class of 
drugs both in the intact rat and in the isolated perfused rat 
liver. 
For the present study the barbiturates have been chosen 
because they are a class of drugs of which the physical-
chemical properties are reasonable well documented. In addition 
the barbiturates are frequently used in therapy. Analytical 
techniques are available for quantitative determination of 
these drugs in small blood samples. 
This study has been carried out in the Research Unit on 
Pharmacokinetics of the Department of Pharmacology, Medical 
School, Nijmegen, The Netherlands. 
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INTRODUCTION 
Drugs, used for the induction of sleep, are known from 
early history of mankind. Initially, alcoholic solution and 
preparations of the "Papaver somniferum" have been used for 
this purpose. 
At the end of the last century, an important group of 
hypnotic drugs have been introduced which are known as 
barbiturates (Fisher and von Mering, 1903). The barbiturates 
are used not only as hypnotic drugs but also as sedatives 
and for the initiation of narcosis. Obviously, for the 
induction of narcosis, a barbiturate with a short action is 
of advantage, while for a sedative effect, a drug with a long 
duration of action is preferred. 
From the study in rats and rabbits, a large difference 
in the duration of action of the barbiturates has been ob-
served (Fitch and Tatum, 1932; Werner e.a., 1937). From this 
and other findings, the concept of the classification of 
barbiturates in ultra short, short, intermediate and long 
acting categories has been formalized (Tatum, 1939). This 
classification has been endorsed by several text books 
(Paton and Paine, 1968; Maynert, 1965; Laurence, 1966; Bacq 
e.a., 1955). 
The classification was strongly challenged by Mark 
(Mark, 1969) in a paper entitled: "Archaic classification of 
barbiturates", where he points out that in clinical situations 
there appeared to be hardly any difference among the hypnotic 
barbiturates in the duration of action as indicated by the 
incidence of hangover the next day. The duration of hypnosis 
obviously correlates with the time at which the drug concen-
tration in the central nervous system stays above a minimal 
hypnotic level. Such concentration is directly related to 
levels of the drug in the blood plasma. It should therefore 
be possible to group the various barbiturates together 
according to the time they persist in the body. 
The biological half-life is a reasonable index for the 
time drugs persist in the body. In man, the biological half-
life of only a few barbiturates has been determined. See 
table 1. From this table it may be seen that hexobarbital has 
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a relative short half-life of about 3 hours; that butobarbital 
has a rather long half-life of about 40 hours and that phéno-
barbital and barbital have a very long half-life of 70 - 90 
hours. The biological half-life therefore may be used as a 
guide for classification of the barbiturates. It seems likely 
that there is a continuous spectrum but a classification is 
nevertheless meaningful. 
The half-life used here is the parameter that characterizes 
the elimination process of the drug after diffusion-equilibrium 
between the different tissues has been attained. With the ultra-
short acting barbiturate, thiopental, the situation is more 
complicated because the duration of the action is not only 
determined by the elimination, but mainly by the distribution 
of the drug over the body. This characteristic of thiopental 
and possibly of other barbiturates may confuse the picture. In 
other words, a particular drug may be short acting as well as 
long acting, depending on the dose and the way of administration. 
It is obvious that when the rate of elimination is fast, 
the initial blood levels strongly depend on the way of appli-
cation of the drug (oral or otherwise), on the rate of 
absorption and on the rate of distribution when the drug is 
directly introduced into the blood stream. 
The purpose of this study is an investigation of the rate 
of elimination, predominantly the rate of metabolism of a 
number of barbiturates in which the influence of distribution 
over the body is eliminated. Among the great number of barbi-
turates in current use, a selection is made to cover 1. short 
acting, 2. intermediate and 3. long acting groups. See table 2. 
We have studied the kinetics of barbiturates both in the 
intact rat after intravenous injection and in the isolated 
perfused liver preparations. The pharmacokinetic parameters 
a. the total clearance constant, characterizing the elimination 
process in vivo and b. the metabolic clearance constant, 
characterizing the metabolism process in the liver in vitro, 
were compared and interpreted on basis of physical-chemical 
constants of the various barbiturates used. 
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TABLE 1 
Biological half-livee of different barbituratee in man 
B a r b i t u r a t e 
Methohex i ta l 
Hexobarbi ta l 
Th iopenta l 
P e n t o b a r b i t a l 
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B u t o b a r b i t a l 
B a r b i t a l 
Phénobarb i ta l 
t% (h) 
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a d m i n i s t r a t i o n 
P . O . 
p . o . 
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CHAPTER 1 
KINETICS OF DRUG DISTRIBUTION AND DRUG ELIMINATION 
It is generally assumed that drugs produce their 
pharmacological or toxicological effect by reacting with 
specific receptive sites In the living organisms. These 
receptors are located In the target tissue which for 
Instance are the motor-endplates In case of neuromuscular 
blocking agents and the neurons of the brain In case of 
hypnotic drugs. The Intensity of a pharmacological effect, 
according to the occupancy theory (Ariëns, 1964), depends 
on the degree of the receptor occupation which in turn 
depends on the concentration of the drug in the direct 
environment of the receptors and the affinity of the drug 
for the receptors. 
Since all tissues are directly or indirectly supplied 
with blood, the drug concentration in a particular tissue 
le a function of the drug concentration in the blood. 
Following the administration of a drug in man or in 
animal, many processes take place: transport from the 
locus of application to the other tissues, especially the 
blood (absorption process); transport from the blood to 
other tissues as muscle, brain, etc. (distribution process); 
biotransformation in the liver and excretion through the 
kidneys, bile, sweat etc. (elimination process). 
This implies that the concentration of the drug in the 
blood changes as function of the time after application. As 
a consequence, the concentration in the target tissue also 
changes. Therefore, the effect will be some function of time. 
The drug concentration in the target tissue, for instance 
the brain, is in most cases not accessible, but the concen-
tration in the blood or bloodplasma may be measured. 
Pharmacokinetics deals with the rate processes which 
govern the blood concentration as function of time. The 
various processes as drug absorption, distribution and 
elimination may be characterized by rate constants or time 
constants. 
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THE BODY CONSIDERED AS A SINGLE COMPARTMENT 
If a drug is introduced directly into the bloodstream 
by intravenous injection, the drug will be taken up first by 
those tissues that are highly vascularised (kidney, brain, 
liver), somewhat later by less vascularised tissues 
(muscle) and thereafter by poorly vascularised tissues (fat). 
The body may therefore be regarded as a number of compart­
ments which are in contact with the blood or the central 
compartment. In addition to distribution over the various 
compartments, the drug is also eliminated from the central 
compartment by means of metabolism and excretion. See figure 
1-1. 
0 
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Figure 1-1 
Schematic терт e в ent at ion of the ртосеааеа taking place after 
the adminietration of a drug to the body. The drug ie given 
in a dose D in the depot compartment 0 (gastro intestinal 
tract, muscle etc.). It ie absorbed to the blood or central 
compartment 1 (absorption) and transported to the different 
peripheral compartments (distribution). The drug at the same 
time is eliminated by biotransformation in the liver or 
excretion in the urine. The metabolic products undergo the 
same kind of processes at the parent drug» The k's are the 
clearance constants that regulates the movement of the drug 
from one compartment to the other. 
If eKchange of drug between the various tissues and the 
blood plasma is very fast as compared to the rate of elimina­
tion, the body may be regarded as a single open compartment 
with a constant volume. See figure 1-2. The concentration of 
the drug in the various parts of the body may, however, be 
quite different, sothat the volume of the compartment does 
not necessarily reflect a physical reality. This volume, also 
called fictive volume of distribution, is based on the blood 
concentration or blood plasmaconcentration once distribution 
equilibrium has been attained. For instance, if the drug is 
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strongly bound to plasma proteins, the fictive volume of 
distribution will be small, as in the case of some dyes, 
because the concentration in the blood will be very large. 
If, on the other hand, the drug easily accumulates into extra 
vascular tissues, the fictive volume of distribution will be 
very large. For instance amphetamine has a fictive volume of 
distribution larger than the volume of the bodywater. 
DRUG ELIMINATION FROM A SINGLE COMPARTMENT 
Elimination of a drug from the body is analogous to the 
decrease of the concentration of a drug in a vessel in which 
at a certain rate fresh water is pumped and in which the 
volume is maintained constant. See figure 1-2. The elimination 
eubetance in 
fr*eh water flow 
- Œ 
Figure 1-2 
One compartment model. Eydrodynamio and eohematic représenta 
ation. See explanation in the text. 
rate is proportional to the flow of fresh water and the concen-
tration in the vessel. When the elimination progresses, the 
drug concentration decreases and the elimination rate slows 
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Figure 1-3 
Theoretical plasma concentration curves calculated on basis 
of single compartment kinetics. 
a. Curve for a drug with a half-life of 6 hours. Note that 
in each 6 hour period the plasma concentration decreases 
by a factor two. 
b. Curves for drugs with different clearance constants and 
with the same dose and volume of distribution. Note that 
the resultant half-lives are different. 
c. The same curve as in a3 but now plotted on a semilogarithm 
scale. Note that the log of the plasma concentration 
declines linearly with time. 
d. Some of the curves of b3 but now plotted on a semi-logarithmic scale (solid lines). The broken lines show the 
effect of changes in the volume of distribution. It is 
increased by factor two. In these lines the clearance 
constant and the dose are the same as in curve a. Note tha 
the initial concentration is lower and the half-life is 
longer. 
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down. In analogy the elimination rate of a drug from the 
body may be described by the following differential equation 
(Dost, 1968): 
dt el*L ^1' 
where С is the drug concentration in the blood and к , an 
elimination constant with the dimension of a flow constant. 
This constant has been called the elimination-clearance 
constant. After integration the following relation between 
the drug concentration and the time after administration is 
obtained : 
C t - C ' . e - ^ · ' - C0.e"
t / T
^ - c » . ! " ^ (2) 
where r , is the rate constant of elimination, τ , is the el ' el 
elimination time constant (τ , • V-/k , ) , t, is the biological 
half-life (t, • 0.693.τ ,) and С is the concentration of the 
* о 
drug at time t. In addition С is the concentration of the drug 
at the moment of administration. That is after distribution, but 
before elimination did take place. C 0 = D/V-, while D is the 
dose and V. the fictive volume of distribution. 
Theoretical curves for drugs with different half-lives 
as calculated with equation (2) are given in figure 1-3. 
THE BIOLOGICAL HALF-LIFE 
The biological half-life is the time in which the concen­
tration of a drug in the living organism decreases by a factor 
two. In a period equal to the half-life, 50 percent of the 
drug has left the body by metabolism, excretion or otherwise. 
If the drug is mainly excreted the drug is not lost from the 
universe but simple 50 percent left the body in the period 
of the half-life. This is the reason why one speaks of the 
"biological" half-life (Dost, 1968). 
The biological half-life for a particular drug is 
different for different animal species. 
In general the half-life is shorter in small animals such as 
IB 
nwtabolic rat*img/h) 
ISO-. 
trnelh) 
Figure 1-4 
Curvee showing the relationship between the rate of formation 
and drug concentration with a constant V and different К '< 
Note that with a small k the system becomes 
saturated with low concentrations and with a larger К it is 
not saturated. The lower part of the figure shows the drug 
concentration in plasma as function of time in two extreme 
cases: when the enzyme system is not saturated and when it 
is saturated. The first curve can be described in terms of 
first order kinetics and the second in terms of zero order 
kinetics. 
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mice and rats than in larger animals such as dogs and man. 
This is especially the case for drugs that are mainly 
eliminated by metabolic conversion in the liver. The weight 
of the liver in small animals is relatively large (if 
expressed per kg body weight) as compared with the liver in 
large animals. 
The duration of action of a comparative dose of most 
drugs in small animals is shorter than that in large animals. 
In order to produce a comparably effect, relative larger 
doses (in mg/kg body weight) are needed in small animals than 
in man. Nevertheless, studies in rats may be of value for the 
situation in man. 
The biological half-life depends directly on the volume 
of distribution and the elimination clearance constant. In 
formula: 
t, « 0.693.Vf/kel (3) 
Differences in the biological half-life for various drugs may 
reflect differences in the volume of distribution as well as 
the total clearance constant. It is obvious that drugs with 
the same biological half-life are not necessarily cleared at 
the same rate (van Rossum, 1971). 
This should be kept in mind when animals of different 
size and age are used. The weight and the amount of fat mainly 
determines the volume of distribution, but the weight of the 
liver and the bloodflow through the liver mainly determines the 
metabolic clearance constant. The situation is still more 
complex if the biological half-life of a drug in an intact rat 
is compared with that in the isolated perfused rat liver. In 
the latter case the volume of distribution strongly depends on 
the volume of the perfusion fluid of the artificial system. It 
is evident that in such studies not the biological half-lives 
but the total clearance constants should be correlated. 
The biological half-life may easily be calculated from 
the curves obtained by plotting the logarithm of the drug 
concentration in the plasma versus the time after administration. 
In formula: 
log Ct = log C0 - 0.301 t/t, (4) 
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Therefore straight lines should be obtained if indeed the 
body may be regarded as a single compartment. See figure 1-4. 
From the intercept of such lines with the ordinate the initial 
concentration C 0 may be found and from the slope the biological 
half-life may be calculated. 
THE TOTAL ELIMINATION CLEARANCE AND THE METABOLIC CLEARANCE 
The elimination process of a drug is characterised by 
the total elimination clearance constant к .. This constant 
el 
is the sum of the metabolic clearance (k ) for the trans-
m 
formation via the liver, the renal clearance constant (k ) 
for excretion via the kidneys, the alveolar clearance (k ) 
via the lungs and the other clearances via different routes 
like sweat glands, salivary glands etc. 
Except for volatile drugs as the anaesthetic gasses the 
alveolar clearance is not important and the main routes of 
elimination are by means of the liver and the kidneys. 
Therefore in general: 
k
el - km + kr <5> 
The renal clearance depends on the water solubility of 
the drug, the existance of possible active transport mecha­
nism and in the case of acidic or basic drugs also on their 
pK- value and the pH of the urine. Lipophilic drugs are 
Si 
hardly at all excreted via the kidney. The elimination of 
such drugs is predominantly by conversion in the liver to 
hydrophilic metabolites. For such drugs the metabolic 
clearance contributes most to the total elimination clearance. 
THE RELATION OF THE METABOLIC CLEARANCE TO THE METABOLIC 
CAPACITY OF LIVER ENZYMES 
The metabolic clearance of a particular drug depends on 
the metabolic capacity of the liver and the affinity of the 
drug for the metabolizing enzymes. The enzymatic conversion 
of a drug may under the most simple situation be described 
by the following equation: 
21 
D + E Í D E + E + M 
where E is an active site on the enzyme and M the metabolite 
formed by the action of the enzyme. The rate of formation of 
metabolic products (or the rate of disappearance of a drug) 
may be described by the following equation, provided that 
steady state kinetics are valid: 
dM „ "C" „ 1 .,. 
dt m Vmax*K +"CM β Vmax-1+K /,'CH ( 6 ) 
m m 
where V ^ is the maximum rate of conversion for the enzyme max 
with respect to a certain drug. "C" is the concentration of 
the drug in the environment of the active sites and K_ is 
m 
the Briggs Haldane constant being a measure for the affinity 
of the drug for the enzyme. Obviously "C" is some function 
of the drug concentration in the blood. In certain cases "C" 
is directly proportional to the blood concentration ("C" = 
P.C). 
-4 
А К value of 10 M points to a rather good affinity of 
a drug or substance for an enzyme. Most drugs are being 
administered to man in a dose less than 300 mg. This means 
that even for drugs with a rather small volume of distribu-
-4 tion of e.g. 20 l,the molar concentration is less than 10 M 
if the molecular weight is in the order of 300. Many drugs are 
given in even much lower doses sothat the drug concentration 
is in many cases small with respect to the Briggs Haldane 
constant. Under such conditions the rate of disappearance of 
drugs is directly proportional to the quotient of V and К . 
max m 
(7) 
In formula : 
dQ
 ш 
dt 
Therefore! 
к -
m 
V 
max 
К 
m 
P. 
ПрИ 
max m 
(8) 
where к is the real metabolic clearance constant of the liver m 
and Ρ is a proportionality factor or some other function that 
relates the drug plasma concentration to the concentration in 
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the microenvironment of the enzyme system. 
On the other hand, if the concentration is large with 
respect to κ , the enzyme is saturated and the rate of 
product formation is constant and concentration indepen­
dent. 
Then: 
^ = V (9) 
dt max m 
In figure 1-4 the relationship between the rate of formation 
of metabolic products and the drug concentration as well as 
the decay of the drug concentration in the plasma as function 
of time for the two extreme situations that equation (8) and 
(9) hold respectively. 
For alcohol that is taken by man in quantities of 10 -
100 g the metabolic enzymes are saturated. They therefore act 
at maximum capacity, such that per hour about 10 g alcohol is 
oxydized (V__
v
 = 10 g/h). For most drugs when given under 
XuclX 
normal conditions the enzymes seem to be far off from satura­
tion and elimination in a first order process. Obviously in 
cases of suicide or accidental poisoning such high doses may 
be taken that saturation of enzymes may occur. 
Certain drugs, although they may be given in relatively 
low doses may still saturate the enzymes if such drugs pre­
ferentially accumulate in liver cells at sites where the 
metabolic enzymes are located. 
It should be emphasized that the maximum metabolic rate 
may be limited by the blood flow through the liver and the 
transport (diffusion) of drug molecules from the blood to 
the sites of action. These limitations also hold for the 
comparison of in vivo experiments in intact animals with in 
vitro experiments with liver microsomes. In the latter case 
the addition of various cofactors and other substances may 
strongly influence V . Therefore, a correlation between 
in vivo and in vitro results is difficult to make. 
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THE CLEARANCE OF A DRUG BY A PARTICULAR ORGAN 
The clearance of a drug by an organ, as for instance 
the liver, depends not only on the capacity of that organ 
but also on the blood flow through the organ and the rate 
of drug transfer from the blood to that organ. The situation 
may be described by the model shown in figure 1-5. It is a 
schematic representation of the elimination in a one compart­
ment system like the perfused liver. It can be said that 
(Riggs, 1963): 
dQ, dQ
a
 + dQ
r 
(10) 
where dQ, is the amount of drug entering the organ in an 
interval of time dt; dQ_ and dQ,. are the amounts of drug 
a r 
leaving and removed by the organ in the interval of time dt. 
dQ and dQ are equal to: 
Γ cl d Qi и i kf d t and 
d Q
a *
 C
a
kf d t 
where C. and С are the concentrations of the blood entering 
and leaving the liver, and kf is the blood flow through the 
organ. 
Ci 
kf 
Figure 1-5 
Ca 
Sohematio representation of the ieolated perfused liver 
system. 
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If the liver is viewed as a tissue with numerous parallel 
channels through which the perfusate flows. The amount elimina­
ted is a function of the metabolic activity and the contact 
time of a given increment of perfusate with liver tissue. In 
the case of first order kinetics the concentration of the out­
flow will be (Nagashima and Levy, 1968) : 
-tV 
C
a
 - C^e (11) 
where t' is the mean contact time of the perfusate with the 
liver and r' is the rate constant of elimination, t' and r' can 
be represented by the following equations: 
V. к 
Ь
 " k~ a n d r " V~ 
K f Vj^ 
where V. is the volume of the liver and к the real metabolic 
ι m 
clearance. 
Substituting t and r in equation 11 yields: 
C
a
 = С±е
 m r
 (11 a) 
If in equation 10 both sides are divided by dt and С is 
substituted by equation 11 , the result is: 
dQ^ -bJkf 
-^1 = kf(1 - e
 m r)C 1 (12) 
dQ /dt is equal to the amount of drug leaving the system 
(dQ/dt in equation 1) and C. is equal to the blood concentra­
tion in the rest of the compartment (C in equation 1) because 
С mixes immediately with the rest of the blood. Therefore, 
the apparent metabolic clearance constant of this model is: 
-к /k, 
k
n,
 я
™
 β
 M 1 - e m r) (13) 
m app г 
If к is large with respect to k f , the apparent metabolic 
clearance is equal to the blood flow: 
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m app f 
If however к is small with respect to kf, the exponential 
term may be developed according to a McLaurin series. Here 
only the first two terms of such a series are used. This 
leads to the following equation: 
k
n, ««η " M 1 " Ь r21) (13 b) 
m app m κ 
f 
This implies that the apparent metabolic clearance is smaller 
than the real metabolic clearance. It may also be concluded 
that the apparent metabolic clearance will be larger if the 
blood flow through the organ is increased, provided that the 
penetration of drug into the organ is not the rate limiting 
factor. On the other hand, if the real metabolic clearance 
is very small, the apparent clearance constant will be less 
dependant on the blood flow. 
ELIMINATION KINETICS IN ISOLATED PERFUSED ORGANS 
The rate of elimination of a drug by the liver or other 
organ, depends on the clearance constant and the volume to 
be cleared. In formula: 
r
el * v f a n d S - 0 · 6 9 3 Vf/kel 
In the isolated perfused liver a perfusion fluid (volume V ) 
is pumped through the isolated organ (flow k~). The volume 
of distribution of a drug in such a system is determined by: 
f ρ 1 
where V. is the volume of the liver. In most cases the volume 
of the perfusion fluid is much larger than the volume of the 
liver, therefore, the volume of distribution is mainly depen­
dent on the volume of the perfusion fluid. It is obvious that 
if the organ is acting perfectly when isolated (i.e. clearance 
not altered), the half-life of a given drug may be quite 
different from the in situ conditions, because the voltane of 
distribution in the animal may be different to the volume of 
the perfusion fluid. 
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The clearance constant may be used as the kinetic para-
meter characterising the elimination process in both, the 
intact animal situation and the isolated perfused organ, 
because the clearance is independent from the volume of the 
system. It may however be dependent on the blood flow through 
the organ. In the isolated perfused organ the blood flow 
should therefore be kept within the range normally occurring 
in the intact animal. 
MULTICOMPARTMENT PHARMACOKINETICS 
Elimination of a drug from the body is not always fast 
with respect to distribution over the various tissues. This 
implies that the blood may be considered as a central compart-
ment from which elimination occurs while this compartment is 
in diffusion contact with one or more peripheral compartments. 
The blood or bloodplasma curve, when plotted in a semi-
logarithmic scale is not a straight line, but is multiphasic. 
In most cases the plasma curve is biphasic, therefore, the 
data may be interpreted in terms of a two compartment open 
model (Riegelman e.a., 1968). This model may be described by 
the model of figure 1-6. 
When a drug is introduced in the central compartment, 
there is exchange of drug with the peripheral compartment and 
the elimination in the third compartment occurs simultaneous-
ly. 
1 
kn 
* • 
k21 
2 
Figure 1-6 
Open two compartment model with elimination in the central 
compartment. 
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The exchange of substance can be represented by the 
following differential equations: 
dQ. 
dtT * - kl2 Cl + k21 C2 - kel Cl ( l 4 ) 
dQ, 
dt 12C1 K21^2 K ' 
d Q
el 
- # • kel Cl ( 1 6 ) 
where Q. and Q, is the amount of drug in compartment 1 and 2, 
while Q , is the amount eliminated; С is the concentration 
el 
and by?' 1*21 an(* l*©! a r e c l e a r a n c e constants for distribution 
and elimination respectively. 
After integration of equation 14, 15, 16, the following 
equations for the concentration in the central compartment 
and peripheral compartments (C.) are obtained: 
-t/τ. -t/τ-
C 1 = A ^
 1
 + A 2e
 2
 (17) 
-t/τ. -t/τ 
C 2 « B 1e
 i
 + B 2e ^ (18) 
Now there is not a simple relation between the volume of 
distribution and the time constants or biological half-lives. 
In formula: 
1 » .-,kl2*kel . k 2 K .
 1,J/
k12't'kel k21. 2 . kel к21. 
Tl Vl V2 1 V2 Vl V2 
Ve 
к +k к 
i_ = ι,
 (
k12 el
 +
 hi) - W 
T2 Vl V2 ^ 
^ і г ^ е і
 k 2 1 t
2
 .
 k
el k2l, 
v 1 ' v 2 » "
 4 (
v 1 ·ν2 > 
Va 
In general the biological half-life is calculated from the 
largest time constant (t, = 0.693 τ 2 ) . It is obvious that 
this half-life is not only dependent on the clearance con­
stant of drug elimination but also on all other constants. 
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Also the coefficients Α., A 2 and В are not a single function 
of the dose and the volume of distribution. In formula: 
A. = я-
^ T^iV^ei) 
V, ^ ^ 
А
л
 = =-
η - -η =
D k l 2 τ
ΐ·
τ2 2
' ^V^T-fvV 
Experimentally it is possible to calculate the coefficients 
A. and A- and the time constants τ. and r from a biphasic 
blood concentration curve (see figure 1-7). From the dose D 
and this set of values the pharmacokinetic parameters may be 
calculated: 
Vj = D/fA^Aj) and V f = V1.(l+(k12/V1)/(k21/V2)) 
Where V is the volume of the central compartment and V f the 
apparent volume of distribution. The real volume of the peri­
pheral compartment cannot be calculated unless C, is measured, 
VAll* 
Ai 
«г·· 
AT 
-
io"*; 
-
и 
\ \ 
\ \ 
\ 
V \ \ \ 
ν· 
\ 
\ 
г—i 
- — 
Τ,=0.402 h 
q;« ЗЛО-4 mol 
- _ _ _ ^ 
T
z
=5.60eh tl=4.78h 
A2«0.72 Ю-»ы * 
^^ "— -^^ ^^ ^ 
t(h) 
Figure 1-7 
Biexponential curve corresponding to the open two compartment 
model. Note that from this curve it could not be concluded 
whether the elimination takes place in central or peripheral 
compartment. 
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In addition: 
,1 " D / ( T1 A1 + T2 A2 ) (19) 
k12 / Vl * Α 1.Α 2(τ 2-τ 1)
2
 / (Α1+Α2)(τ1.Α1 + τ2·
Α2)τΐτ2 ( 2 0 ) 
k21 / V2 * ( T1 , A1 + τ2· Α2 ) f τΐ τ2 ( Аі + А2 ) (21) 
In the discussion above, it was assumed that the elimination 
occurs in the central compartment. This assumption is true 
with almost all drugs, because the elimination takes place 
in the organs that are highly vascularised like liver and 
kidneys, sothat these organs are part of the central compart­
ment. In case of the kinetics of drug metabolism in the 
perfused liver, if the diffusion of the drug from the blood 
is slowly, the elimination takes place outside the central 
compartment. 
k12 
*2ΐ 
Figure 1-8 
Open two aompartment model with elimination in the peripheral 
compartment. 
In this case, the elimination process occurs in the 
peripheral compartment, which may be represented in the scheme 
of figure 1-8. 
In this case the exchange process can be represented by 
the differential equations: 
dQ 
=. = -ir с + 1c С 
dt К12^1 + K21 2 
(22) 
dQ2 
dt~ = k12Cl " k21C2 " kelC2 (23) 
d Q
el 
dt е1^2 (24) 
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After integration the following equations are obtained: 
-t/τ. -t/τ-
C 1 = A1e
 1
 + A2e
 ί
 (25) 
-t/τ. -t/τ, 
C 2 = Β ι 6
 1
 - B2e
 2
 (26) 
From the plasma concentration curve as such one cannot conclude 
whether elimination occurs from the central or peripheral 
compartment, also now the coefficients and time constants are 
not a single function of the elimination clearance constant 
and the distribution volumes. 
From the plasma concentration curve the coefficients A. 
and A and the time constants τ and τ 2 may be determined. 
The pharmacokinetic parameters then can be calculated. 
V 1 = D/(A1 + A2) 
However, the elimination clearance constant cannot be calcu­
lated . Only the elimination rate constant may be determined. 
el 1 1 
V 2 T l T 2-k 1 2 
The rate constants for the distribution may be determined 
also: 
Íh2
 β
 1_
 +
 1_ ,Αΐ·τΐ * Α2·τ2 j 
V1 τ1 τ2 Ъ
 + Α2· τΐ· τ2 
k 2 1 _ 1 1 . 
V2 τ , τ 2 
k 1 2 
V l 
k
e l 
V 2 
It should be realized that if one is not sure that elimination 
does take place in the central compartment one may make large 
errors in the calculation of kinetic parameters from plasma 
concentration curves. This is especially true for the elimina­
tion clearance constant к ,. 
el 
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CURVE FITTING IN CASE OF MULTICOMPARTMENT KINETICS 
The plasma or blood decay curve in case of multicompart­
ment kinetics in general may be represented by the following 
equation (Georgi and Segre, 1970): 
η -t/τ. 
С = Σ A.e i (27) 
i=l 1 
The problem is to fit a set of measured data with this 
equation. From the time constants τ. and coefficients A. thus 
obtained, the pharmacokinetic parameters may be calculated. 
Curve fitting may be done in the following way: 
a. by hand. The concentration data are plotted on logarithmic 
paper versus the time in a linear scale. From the data 
measured at times that exceed the largest τ. a straight line 
may be obtained. From this line A and τ can be calculated. 
η η 
By a substraction method the next smaller set τ , and A , 
2
 n-1 n-1 
may be found. 
b. by the use of an analog computer. With this method the 
pharmacokinetic parameters are varied until the curve fits 
the data. The parameters may then be read from the analog 
machine. 
c. by the use of a digital computer with a linear or preferably 
nonlinear least square curve fitting program. In case of a 
single compartment model (one exponential term) a linear 
least square method is sufficient. 
Mr. G. Fast of the Department of Theoretical Physics has 
developed a nonlinear program by which the data can be 
fitted to equation 27, With this socalled FARMFIT program, 
data, errors in the data and other indications are read into 
the computer. Thereafter estimates of τ. and A. are read in. 
By an iterative procedure the best τ.'s and A.'s are then 
found. 
Actually, the fitting of the curves to к data sets 
were carried on by finding the minimum of: 
-t/τ. 
C. η A.e 
-L· - E —-
к 
XSQ - Σ error j . error j (28) 
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In the present study there are only two A's and two T'S. 
From these values the pharmacokinetic parameters are calcu-
lated according to equations for the open two compartment 
model. These parameters are presented with errors that depend 
on the corresponding errors of the calculated A's and T'S, 
which in turn depend on the errors of the data. 
SUMMARY 
In order to get an understanding of the pharmacological 
effect of a drug, it is necessary to know its concentration 
at the active sites. Following the administration of a drug 
in man or an animal, many processes take place. This implies 
that the concentration of the drug in the tissues changes as 
function of time. In most cases the only tissue accessible 
for analysis of the drug content is the blood. Pharmacokinetics 
deals with the rate processes which govern the blood concen-
tration as function of time. When a drug is introduced directly 
in the bloodstream, it will be taken up by the different 
tissues. If this process is fast with respect to elimination, 
the body may be regarded as a single open compartment with a 
constant volume. This volume, called volume of distribution 
or fictive volume of distribution, may vary in size according 
to the drug used. 
The elimination of a drug from the body almost always 
takes place in an exponential fashion. The rate of elimination 
may be described in terms of rate constants, time constants or 
half-lives. Theoretical curves of drug decay in a singel com-
partment are presented in figure 1-3. 
The biological half-life is the time in which the concen-
tration of a drug in the living organism decreases by a factor 
two. This constant for a particular drug is different in 
different animal species. It depends directly on the volume of 
distribution and the elimination clearance constant. 
The total elimination clearance constant characterizes 
the elimination process. It is equal to the sum of all the 
clearance constants (metabolic, renal, alveolar etc.). The 
value of the metabolic clearance constant is related to the 
enzymatic activity and the blood flow through the liver. 
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With some drugs, the assumption that the body behaves as 
a single compartment, does not hold. In those cases a multi-
compartment model is used. Generally, a two compartment model 
describes the time course of the drug in the body. A two com-
partment model may also be used in certain cases in the isola-
ted perfused liver, but this model differs from the previous 
in the site of elimination. In the first, elimination takes 
place in the central compartment while in the second in the 
peripheral compartment. 
In order to calculate the pharmacokinetic parameters 
the blood curve must be fitted to the data points. The best 
ways of fitting are the procedures using the least square 
fitting. Because of the complexity of this method, a digital 
computer must be used. 
RESUMEN 
Para poder producir el efecto deseado, una droga debe 
estar en la concentración adecuada en el lugar que se encuentran 
los receptores o biofase. Cuando una droga es administrada a un 
animal o a un hombre, por medio de diferentes procesos ésta es 
absorbida, distribuida y eliminada del cuerpo. Es decir que la 
concentración de la droga en los diferentes tejidos es una 
función del tiempo. La mayoría de las veces el único tejido 
accesible es la sangre. La farmacocinética es la ciencia que 
estudia los procesos que gobiernan la concentración de un 
medicamento en la sangre y diferentes tejidos. 
Cuando una droga es administrada directamente en el 
torrente sanguíneo, ésta se distribuye a todos los tejidos. 
Si este proceso es muy rápido con relación a la eliminación, 
al cuerpo se lo puede considerar como compuesto por un solo 
compartimiento. Este compartimiento tiene un volumen fijo 
para cada droga y se llama volumen de distribución o volumen 
ficticio de distribución. 
Generalmente, las drogas son eliminadas del cuerpo en 
forma exponencial. A este proceso se lo puede describir por 
medio de constantes de velocidad, constantes de tiempo y 
constantes de hemivida. En la Fig. 1-3 se muestran ejemplos de 
curvas teóricas de concentración en sangre. 
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La hemivida biológica es igual al lapso en el cual la 
concentración de una droga en el organismo se reduce a la 
mitad. Una misma droga generalmente tiene distintas hemividas 
en diferentes especies. Ella depende del volumen de distri-
bución y de la constante de aclaramiento total. 
La constante de aclaramiento total es el parámetro que 
caracteriza el proceso de eliminación. Ella es una suma de 
diferentes constantes de aclaramiento (renal, metabòlica, 
alveolar etc.). El valor de la constante metabòlica de aclara-
miento depende principalmente de la actividad enzimàtica y del 
flujo sanguineo a través del hígado. 
Con ciertas drogas, al cuerpo no se lo puede considerar 
como formado por un sólo compartimiento. En estas circunstancias 
se hace necesario usar modelos de varios compartimientos. General-
mente un modelo con dos compartimientos es suficiente en estos 
casos. Aguí la concentración de la droga en la sangre decrece en 
forma biexponencial. También se puede usar un modelo de dos 
compartimientos para describir la cinética de algunas drogas en 
el hígado de rata aislado y perfundido. Estos modelos difieren 
entre si en que en el primero la eliminación occure en el com-
partimiento central y en el segundo en el periférico. 
Para poder calcular los parámetros de una droga, la función 
фіе describe la concentración en sangre tiene que ser ajustada a 
los resultados experimentales. La forma más usada para lograr 
esto es encontrar los parámetros que reducen a un mínimo la 
suma de los cuadrados de las diferencias entre los valores 
calculados y los medidos en forma experimental. Este cálculo, 
debido a su complejidad, sólo se puede hacer por medio de 
computadoras digitales. 
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CHAPTER 2 
EXPERIMENTAL PROCEDURES FOR THE ESTIMATION OF CONCENTRATION-TIME 
CURVES IN THE INTACT RAT AND THE ISOLATED PERFUSED RAT LIVER 
For a careful analysis of blood concentration curves in 
an intact rat, following administration of a drug, sufficient 
blood samples have to be taken at the right time-intervals. 
This implies that frequent sampling has to be done if the 
blood concentration changes rapidly, while on the other hand 
samples have to be taken only occasionally if the blood 
concentration changes slowly. The total blood volume of the 
adult rat is about 12 ml. Therefore the size of the samples 
has to be small to allow sufficient samples to be drawn 
without inducing alterations in the cardiovascular system. It 
could be shown that 8 samples of 0.5 ml blood may be taken in 
an experiment that lasts 2 hours. It is also possible to use 
a large number of rats and to take a fairly large sample in 
each rat by cardiac puneture.With such a procedure information 
is lost because of individual variation even in inbred rats. 
Since we intend to make a correlation of the kinetic para-
meters in the intact rat and the isolated liver of rats, we 
made concentration-time curves in single rats. In the isolated 
perfused rat liver experiments the volume of the samples must 
also be small with respect to the volume of the perfusion fluid. 
This is, however, less a problem, since the perfusion fluid may 
be increased at will. The small sample size may lead to 
difficulties with respect to the sensitivity of the analytical 
techniques. Therefore, the sensitive methods which furthermore 
can easily be adopted for the various barbiturates, should be used. 
The experimental techniques used in the present study will be 
discussed in three sections: 
The isolated perfused rat liver. 
The intact rat. 
The analytical methods for the quantitative determination of 
the barbiturates in blood. 
37 
THE TECHNIQUE OF THE ISOLATED PERFUSED RAT LIVER 
The use of the isolated rat liver perfused with blood 
of other rats, has first been successful in 1951, when two 
teams of American researchers introduced this technique as 
a tool in physiology and biochemistry (Brauer е.a., 1951; 
Miller e.a., 1951). The liver of a lightly anaesthesized rat 
is rapidly isolated after the canulation of the vena porta, 
the vena cava and the bile duct. 
The liver is perfused by oxygenated blood that flows 
into the vena porta. The operation has to be done under 
sterile conditions and rapidly in order to prevent stasis of 
the blood in peripheral parts of the liver. The liver is sus­
pended in a closed liver chamber and connected to a perfusion 
system. Oxygenated blood is kept circulating through the 
system by means of a circulation pump. 
In the early techniques, pooled rat blood was used, 
therefore a large number of rats was needed in order to obtain 
enough blood for the perfusion system. A major change was 
introduced by Schimassek (Schimassek, 1962 a), who used a 
semiartificial perfusate containing bovine red blood cells 
and bovine albumin instead of rat blood. 
The technique of the isolated perfused rat liver is now 
a classical one and is used by different groups of investiga­
tors, mainly in the field of pharmacology, toxicology, bio­
chemistry, drug metabolism etc. (Baggiolini e.a., 1969; Von 
Bahr e.a., 1970; Fisher and Kerly, 1964; Hems e.a., 1966; 
Kaiser e.a., 1965). 
Similar techniques have been used with livers of other 
laboratory animals (Young e.a., 1955; lacobescu e.a., 1968; 
Trinker and Rand, 1970). In The Netherlands, the technique 
of the isolated perfused rat liver has first been introduced 
in the Pharmacological Laboratory of the University of 
Groningen, where we have gained our experience. In this 
laboratory we used the technique of the isolated perfused rat 
liver according to Miller, with a number of modifications, 
while as perfusion fluid a suspension of bovine erythrocites 
and artificial plasma is used. 
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The apparatus 
The apparatus is similar to the one used by Miller, 
though a number of improvements have been introduced. It 
consists of: 
a. The liver chamber, which is closed and is kept humid in 
order to prevent drying out of the liver. 
b. The reservoir, where the blood, coming from the liver, is 
collected. 
c. The pump, by which the blood is pumped from the reservoir 
to the oxygenator. 
d. The oxygenator, where the blood is oxygenated by a flow of 
oxygen. 
The system is a closed circuit and a constant volume of 
perfusate is made to circulate. See figure 2-1. 
a. The liver chamber. The liver chamber is made of perspex, 
containing a perforated polyethylene sheet on which the 
liver is suspended with the diaphragmatic side down. At the 
bottom of the liver chamber there is a small calibrated 
recipient used in measuring the blood flow. 
b. The reservoir. The reservoir has a funnel shape in order 
to use different volumes of perfusate, especially the small 
ones. The upper part of the reservoir has four openings: one 
for the blood coming from the liver; one for the connection of 
the reservoir with the oxygenator; one for the thermometer and 
one for the flow of oxygen and carbondioxide. 
c. The pump and the filter. The pump is a roller pump (Cardiac 
Suction Unit, type 913, New Electronic Products Ltd., London) 
and it is used for pumping the blood from the reservoir to the 
top of the oxygenator. A dischargeable filter taken from a 
transfusion set is interconnected to collect blood clottings. 
d. The oxygenator. The circumferential troughs of the oxygenator 
permit the pooling of the blood that flows down. The oxy-
genator is designed for allowing a good filming of the blood. 
A fraction of the blood, coming from the oxygenator, goes 
directly to the liver and the rest flows over into the reservoir. 
This design is similar to the one used by Fisher and Kerly 
(Fisher and Kerly, 1964). 
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Figure 2-1 
Sahematio drawing of the apparatus used for the isolated 
perfused rat liver. 
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Functioning of the apparatus 
The blood is pumped up to the top of the oxygenator, then 
films down through it and accumulates at the bottom. Part of it 
goes directly to the reservoir and part to the liver and after-
wards to the reservoir. The perfusate gets into the liver via a 
canule in the portal vein and flows freely through the cutting 
ends of the cava vein. In opposite direction to the blood, 
circulates a gas mixture of oxygen (95%) and carbondioxide (5%). 
It goes out through the upper part of the oxygenator. The gas 
mixture is humidified before passing through the upper part of 
the oxygenator. Actually, the gaseouse exchange takes place not 
only in the oxygenator but also in the reservoir and the over-
flow tube. The oxygenator is situated at a fixed distance from 
the liver chamber in order to get a constant pressure during 
the whole experiment. The distance, measured from the upper 
level of the blood, is 16 cm. 
The apparatus is housed in a perspex box that is kept at a 
constant temperature (39 C) by means of a fan and a resistance 
connected to a thermostate. Water is spurred on the floor of the 
cage in order to keep the air humid and allow a good thermal 
exchange between the apparatus and the air. 
Perfusion liquid 
The perfusate is prepared according to the one used by 
Schimassek (Schimassek, 1962 a). A solution is made containing 
per liter the following salts: NaCl, 137 mM; KCl, 2.68 mM; 
CaCl,, 1.80 mM; MgCl2, 0.49 mM; NaHCOg, 11.9 mM and NaH2P04. 
H50, 0.67 mM. It is prepared in two concentrated stock 
solutions and thereafter mixed, diluted and sterilized through 
a millipore filter. 
100 ml of human blood are centrifugated, the plasma is 
removed by suction and afterwards the red cells are washed 
three times with Schimassek saline solution. 40 ml of the 
washed erythrocites are mixed with the following solution: 
bovine albumine, 3 g; glucose, 0.150 g and Schimassek saline 
solution 30 ml. It is made up to 100 ml with Schimassek 
solution. The preparation of the "artificial" blood is done 
under strict sterile conditions to avoid bacterial contamination. 
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Preparation of the apparatus for иве 
The apparatus is carefully washed and rinsed, first with 
abundant tap water and afterwards with dlstlled water. When 
the apparatus Is set up, a solution of formol (5%) and sodium 
bicarbonate (15%) is put in circulation. After an hour this 
solution is removed. In order to eliminate the formol, 
Schimassek solution is made to circulate in different portions 
and several times. The last portion is replaced by the per­
fusion liquid and is kept in circulation until it reaches the 
right temperature. 
Liver operation 
Male Wistar rats, weighing from 190 g - 120 g, from the 
stock of the Animal Laboratory of the Medical School, were 
used in the experiments. The operation was performed under 
light ether anaesthesia. The abdomen is opened and the 
abdominal viscera exposed. The esophagus and the accompaning 
vessels are cut between two ligatures. The bile duct is iso­
lated and canuled, while the arterica hepática is ligated. 
Heparine is injected into the cava vein. Five minutes after 
the portal vein is canuled, the liver is isolated and connected 
to the apparatus. The vena cava is not canulated sothat the 
blood entering the liver via the vena porta leaves the liver 
via the cutting ends of the vene. 
Control of liver performance 
The criteria used to control the performance of the liver 
were: bile production, blood flow and the macroscopic aspect 
of the liver. The total bile production during a 4 hours 
perfusion was 2 - 3 ml, having a maximum at the start and 
decreasing afterwards. The blood flow varied from one experi-
ment to another and it was within 16 - 18 ml/min. After 30 
minutes the flow becomes constant along the perfusion. The 
aspect of the liver must be clear, that is to say, without 
ischemic spots. According to the literature, these three 
characteristics are best signs of the liver performance 
(Brauer e.a., 1951; Brauer е.a., 1954; Jeunet е.a., 1962). 
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Conditione of the liver during the perfusion 
In order to be able to draw conclusions from the data 
obtained from a system like the perfused liver, we must know 
what are the conditions of this system. In other words, when 
we are working with an artificial system, we must determine 
how artificial it is. 
Four major factors have been altered in the perfused 
liver with relation to the liver in situ, they are: the 
quality of the perfusate, the oxygenation, the hemodynamics 
and the volume of the perfusate. 
- The quality of the perfusate. Schimassek and other researchers 
(Schimassek, 1962 a, 1962 b; Jeunet e.a., 1962; Rutter e.a., 
1961; Meyer-Brunot e.a., 1968) have shown that the conditions 
of the perfused liver were similar when it was perfused with 
a semisynthetic medium or with whole blood. 
- Oxygenation. In the intact animal the liver gets the blood 
through the portal vein and the hepatic artery. The delivery 
of the oxigen to the liver is done via the both vessels. The 
oxigen content of the portal vein depends on the metabolism of 
the intestine and other organs from where the blood comes from 
the blood flow and therefore the delivery of oxigen to the 
liver, of the hepatic artery changes according to the amount of 
oxigen dissolved in the portal blood. In the isolated liver the 
blood entering the vena porta, is completely oxygenated sothat 
via the vena sufficient oxigen is brought into the liver. This 
means that the Art. hepática then has no function (Brauer, 1963). 
- Hemodynamics. The principal functional difference between the 
perfused liver and the liver in the whole animal is that the 
liver is perfused only through the portal vein. In spite that 
it is not the same situation as in the whole animal, a good 
supply of blood is assured to all parts of the liver, because 
of the close connection between the portal and arterial beds 
(Brauer, 1963). Another difference between the liver in vitro 
and in vivo is that the perfused liver is in vasodilatation. 
It is due to the lack of the "vasoconstrictive substance" 
present in the blood in the whole animal. This substance is 
inactivated by the liver itself (Brauer e.a., 1953). As a 
consequence, the blood flow through the liver in the isolated 
system is larger than in the intact rat. 
43 
- Volume of the perfusate. The volume adopted is 100 ml. 
In the animal the blood volume Is approximately 12 ml 
(Spector, 1956). But the real volume of distribution of each 
substance dissolved in the blood (glucose, lactic acid, piruvic 
acid etc.) may be larger or smaller than the volume of the 
blood. In general, there is not an optimal volume of perfusate. 
The volumes used should be adopted according to the apparatus 
and the type of drug used. The volume may not be too large 
because then the blood time curve would be flat; it may not 
be too small, because then there would be a quick accumulation 
of the metabolic products of the liver, since in the isolated 
liver polar metabolites are not removed as is the case in the 
intact rat. 
Determination of the metabolic clearance constant in the 
ieolated perfused rat liver 
After the liver was isolated and connected to the apparatus, 
it was allowed to stay there at least 30 minutes in order to let 
the whole preparation to stabilize. At this time the drug was 
added to the perfusate. The doses added was calculated according 
to the volume of distribution of the barbiturate in the animal. 
In the apparatus this volume is approximately equal to 100 ml. In 
this way the initial concentration in the perfusate was in the 
same range of the initial concentration found in the animal 
experiments. The drugs "injected" in the apparatus were prepared 
like the ones used in the animal experiments. At various periods 
samples were drawn from perfusate in the apparatus and the drug 
content analyzed. These values were plotted against the time 
after administration on semilogarithmic paper and graphically 
fitted to a monoexponential curve corresponding to equation 
of chapter 1. The constants calculated in this way were used as 
initial values for a computer program (Fast, 1970) for the 
fitting of the curve and calculation of the kinetic parameters 
corresponding to the one compartment model. See following para-
graph. 
INTACT RAT EXPERIMENTS 
Male Wistar rats from the Animal Laboratory of the 
University of Nijmegen were used. The weight of the animals was 
approximately 200 g. The drugs were injected as a solution of 
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their sodium salts. They were freshly prepared using the 
sodium salt if commertially available or preparing it with the 
free acid and an eguimolecular amount of sodium hydroxide. 
The injection was given under light ether anaesthesia in the 
dorsal vein of the penis. 
0.5 - 0.8 ml of blood were drawn at different periods of 
time after the injection and the drug content determined. The 
samples were taken through orbital puncture using heparinized 
microhematocrit tubes sharpened in one end. The blood was 
collected in tubes containing a minute amount of héparine. 
When the anaesthetic effect of the barbiturate weared off, the 
animals were lightly anaesthesized with ether during the blood 
sampling. The drug content of the samples was plotted against 
the time after administration on a semilogarithmic paper and 
graphically fitted to a biexponential curve described by 
equation 17 of Chapter 1 , corresponding to the two compartment 
model. These constants were used as initial values in the com-
puter program Farmfit (Fast, 1970) for the fitting of the curve 
and calculation of pharmacokinetic parameters. This program finds 
the least-square fit to a set of data with a multiexponential 
function. It finds the minimum for the equation 28 of Chapter 1. 
It was used for both, the intact rat and isolated perfused rat 
liver experiments. 
The data given to the computer includes the dose, the weight 
of the animal, the initial estimates of the A's and the x's and 
the experimental data together with their errors. Throughout this 
study the error in the data has been fixed at 10%. Considering 
the errors in the time of sampling, the sample size and the ana-
lytical techniques this procedure seems to be valuable. It is 
realized that immediately after injection the error in the data 
is less than 10% but the error in the time of sampling is larger. 
At the lower end of the blood decay curve errors in the data may 
be sometimes be larger than 10%. 
QUANTITATIVE DETERMINATION OF THE BARBITURATES 
Sample analysis: It was done according to the procedure 
described by Jain (Jain and Kirk, 1967). To an aliquot of the 
sample (0.3 - 0.5 ml) an internal standard dissolved in 0.1 ml 
of ethanol was added. Afterwards, it was extracted twice with 
a mixture of ether-acetone 1:1. The ether-acetone extracts 
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were redissolved in a small volume of chloroform or methanol 
and an aliquot of this solution analyzed in the gas Chromato­
graph. The drug content was calculated from the relation to the 
areas under the peaks of the gas chromatogram corresponding to 
the compound being analyzed and the internal standard used. 
The volume of sample injected was 2.5 microliters. The internal 
standard was a barbiturate with a retention time different to 
the one used. 
Instruments: The instruments used were a Becker Delft 409 
gas Chromatograph, an HP 400 gas Chromatograph and an HP 402 gas 
Chromatograph, all equipped with flame ionization detectors. 
Two columns were used for the separation of the barbiturates. 
For general purposes a glass column packed with 5% silicon 
gum SE-30 on Diatoport S 60/80 mesh was used. In some special 
cases, when a more polar liquid phase was desired in order to 
reduce the peak tailing, a column packed with 3% SE-30 and 1% 
Carbowax 20M terephtalic acid terminated on Diatoport S 60/80 
mesh was used. The packing was prepared by dissolving the 
liquid phase in chloroform. This solution was mixed with the 
supporting material and evaporated on a heating plate with 
continuous stirring. The resulting powder was then put in an 
oven and kept at 100 С overnight. The carrier gas was 
Nitrogen and its flow was 30 ml/min. The oven temperature was 
190° - 200 С and the injection port and the detector were kept 
at 50° С higher than the oven temperature. 
SUMMARY 
In this chapter are discussed the experimental procedures 
used in the present investigation. Because of the kind of 
animals used (rats), only small blood samples can be taken, 
therefore, a sensitive method of determination has to be used. 
The experimental technique consists of three major parts: the 
isolated perfused rat liver, the intact rat experiments and 
the analytical methods for the quantitative determination of 
the barbiturates used. 
The liver of a lightly anaesthesized rat is rapidly 
isolated after the canulation of the vena porta and the bile 
duct. The organ is perfused with a fixed volume of a semi-
artificial fluid containing human red blood cells and bovine 
46 
albumin. The oxygenated perfusion fluid flows into the vena 
porta and goes freely through the cutting ends of the cava 
vein. In opposite direction to the blood circulates a gas 
mixture of oxygen (95%) and carbon dioxide (5%). The perfusion 
apparatus is shown in figure 2-1. It consists of: a liver 
chamber, which is closed in order to prevent drying up of the 
liver; a reservoir, where the blood is collected; a pump, by 
which the blood is pumped from the reservoir; an oxygenator, 
where the blood is put in contact with the gaseous mixture. 
It is housed in a perspex box kept at a constant temperature. 
The air inside the cage is kept humid in order to allow a 
good thermal exchange between the apparatus and the air. 
The liver performance was controlled by checking the blood 
flow, the bile production and the macroscopic aspect of the 
liver. The drug elimination capacity of the liver was 
measured by adding a drug to the perfusion fluid and at 
different periods of time perfusate samples were drawn from 
the apparatus and the drug content measured. Using these 
values, the kinetic parameters corresponding to the one com-
partment system were calculated. For this purpose, a computer 
program was used. 
In the intact rat experiments, water solution of the 
sodium salt of the drugs were i.v. injected. Blood samples 
were drawn at different periods of time after the injection 
and the drug content determined. These concentrations were 
used to calculate the kinetic parameters corresponding to the 
two compartment system. For this purpose a computer program 
was used. 
The drug content of the samples from the isolated 
perfused liver and the intact rat experiments was determined 
by gas chromatography. The blood samples were extracted with 
a mixture of ether-acetone 1:1. The ether-acetone extracts 
were evaporated under a stream of air and redissolved in a 
small volume of chloroform or methanol and an aliquot of this 
solution analyzed in the gas Chromatograph. The instruments 
used were equipped with flame ionization detectors. Two 
different columns were used for the separation of the drugs. 
Both were glass columns and the packing was 5% SE-30 on 
Diatoport S 60/80 for one column and 3% SE-30 and 1% carbowax 
20M terephtalic acid terminated on Diatoport S 60/80 for the 
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other. Nitrogen was used as carrier gas. The oven temperature 
was 190° - 200° С and the injection port and detector were 
kept at 50° higher than the oven temperature. 
RESUMEN 
En este capítulo se describen las técnicas usadas en la 
presente investigación. Debido al tipo de animales usados 
(ratas) solo se pueden obtener pequeñas muestras de sangre, 
por lo tanto se ha de disponer de un método muy sensitivo para 
poder determinar la concentración en sangre de las drogas usa-
das. Ά las técnicas usadas se las puede dividir en tres partes: 
el hígado de rata aislado y perfundido, los experimentos reali-
zados con la rata y las técnicas analíticas usadas para la 
determinación de los barbitúricos. 
Al hígado de una rata ligeramente anestesiada se le coloca 
una cánula en la vena porta y el conducto biliar. Luego el 
órgano es aislado y conectado a un aparato en el cual se lo per-
funde con volumen fijo de un líquido de perfusión semiartificial. 
Este líquido de perfusión está compuesto de eritrocitos humanos 
lavados y albúmina bovina suspendidos en una solución isotónica 
conteniendo diferentes clases de sales. El líquido de perfusión 
oxigenado entra en el hígado por la vena porta y sale por los 
extremos cortados de la vena cava. En dirección opuesta a la 
sangre circula una mezcla de oxígeno (95%) y anhídrido carbónico 
(5%). Al aparato usado para la perfusión del hígado se lo mues-
tra en la figura 2-1. Las partes principales son: la cámara para 
el hígado, la cual está cerrada para mantener húmedo el hígado; 
el reservorio, para contener la sangre; una bomba, por medio de 
la cual la sangre es puesta en circulación; y un oxigenador, 
donde la sangre es puesta en contacto con la mezcla gaseosa. 
Todo el aparato está dentro de una caja de plástico rígido 
transparente que se mantiene a temperatura constante (39°). 
Al aire dentro de la caja se lo mantiene húmedo para facilitar 
el intercambio térmico entre el aire y el aparato. El funciona-
miento del hígado fue controlado por medio de: el flujo de 
sangre a través del hfgado, la producción de bilis y el aspecto 
macroscópico del hígado. La capacidad metabòlica del hígado se 
midió en la siguiente forma: la droga en estudio se agregó al 
líquido de perfusión y luego de esto, a diferentes períodos de 
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tiempo se sacaron muestras de éste y se analizo el contenido de 
la droga usada. Por medio de estos valores se calcularon las 
constantes cinéticas correspondientes al modelo de un comparti-
miento. Para este fin se uso una computadora programada especial-
mente para solucionar problemas farmacocinéticos. 
En los experimentos realizados con la rata se inyectaron 
i.V. soluciones acuosas de la sal sódica de las drogas usadas. 
Se tomaron muestras de sangre a diferentes períodos de tiempo 
después de la inyección. La concentración de la droga se 
determinó en cada una de las muestras. Estos valores fueron 
usados para calcular las constantes cinéticas correspondientes 
al modelo abierto de dos compartimientos. A este fin se usó 
una computadora programada especialmente para la solución de 
problemas farmacocinéticos. 
La concentración de las drogas en las muestras prove-
nientes del hígado aislado y perfundido y de la rata fueron 
analizadas por medio de cromatografía de gases. Las muestras 
fueron extraídas con una mezcla eter-acetona 1:1. Estos extrac-
tos fueron evaporados y el residuo redisuelto en un pequeño 
volumen de cloroformo o metanol. Parte de esta solución fue 
analizada en el cromatógrafo de gases. Estos instrumentos 
estaban equipados con detectores de ionización de llama. Dos 
columnas de vidrio se usaron para la separación, una estaba 
llenada con 5% de SE-30 sobre Diatoport S 60/80 y la otra con 
3% de SE-30 y 1% de carbowax 20M terminado con ácido tereftá-
lico sobre Diatoport S 60/80. Nitrógeno se usó como gas de 
transporte. La temperatura del horno fue 190° - 200° y la del 
lugar de inyección y el detector 50° más alta que la del horno. 
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CHAPTER 3 
KINETICS OF ELIMINATION OF HEXOBARBITAL AND PENTOBARBITAL 
IN THE INTACT RAT AND THE ISOLATED PERFUSED RAT LIVER. 
According to the usual classification of barbiturates, based 
on the length of the action in small animals (Mark, 1969) , 
hexobarbital and pentobarbital are included in the ultra-short 
and short acting groups respectively (Sharpless, 1970; Parke, 1971; 
McArdle, 1971; Martindale, 1969). 
Hexobarbital exhibits a very short-lasting effect in man and 
in small animals (Quinn e.a., 1958). It was used as an inducer in 
general anaesthesia because of the rapid onset and short duration 
of the action. 
Pentobarbital has been classified as a short, but also as an 
intermediate acting barbiturate. It is used mainly as a hypnotic 
and occasionally as a sedative. In laboratory animals it is used 
as an anaesthesic agent. 
In order to obtain information on the relative role of the 
rate of distribution and metabolic elimination, the kinetics of 
both barbiturates were studied in the intact rat and in the 
perfused liver. 
METHODS AND MATERIALS 
Experimental méthode 
Male wistar rats were used in both the intact rat and perfusion 
experiments. 
Six animals were injected i.v. with 14.7 mg (equivalent to 73.5 
mg/kg) of hexobarbital and 7 animals with 5.4 mg (equivalent to 
27 mg/kg) of pentobarbital. Blood samples were taken at regular 
time intervals and the drug content determined (see table 3-1 
and 3-2). Pharmacokinetic parameters were calculated from the 
drug concentration as a function of time after administration 
(see Chapter 1 and 2), 
In the liver perfusion experiments, 5 - 10 mg of hexo-
barbital and 4.56 mg of pentobarbital were added to 100 ml of 
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Figure 3-1 
lo.o го.о 
TINE MINUTES) 
50.0 
Blood concentration verвив time, following intravenous 
adminietration of eodium Eexobarbital (73.5 mg/kg of the 
free acids rat number 6). The pointe represent individual 
experimental values, whereas the line is the beet fit 
according to the computer program for a biexponential curve 
mentioned in chapter 2. 
100.0 120.0 140.0 160.0 180.0 200.0 
figure 3-2 TIME (MINUTES) 
Blood concentration vereue time, following intravenous 
adminietration of sodium Pentobarbital (26.Ζ mg/kg of the 
free acid; rat number 11). The pointe represent individual 
experimental values, whereas the line is the best fit 
according to the computer program for a biexponential curve 
mentioned in chapter 2. .. 
perfusion fluid 30 minutes after the perfusion began. Perfusion 
fluid samples were taken at regular time intervals and the drug 
content determined (see tables 3-3 and 3-4). Kinetic parameters 
were calculated from the drug concentration in the perfusate as 
a function of time after administration (see Chapter 1 and 2). 
Two rats (rat 7 and rat 8) which were used in the intact 
animal experiments with pentobarbital, were used again after 
one week as liver donors in the perfusion experiments (perfusion 
17 and perfusion 18 respectively). 
Drugs 
The commercially available sodium salt of hexobarbital 
especially prepared for i.v. injection was used. A solution of 
30 mg/ml was prepared. Therefore, the volume of liquid injected 
to the animals or added to the perfusate was in the order of 
0/5 ml, but always smaller than 1 ml. 
Pentobarbital solution of 60 mg/ml as used for veterinary 
purposes as such was employed in the animal and perfusion 
experiments. 
Analytical methode 
The drug content was determined as has been described in 
Chapter 2. Pentobarbital was the internal standard in case of 
the hexobarbital experiments, whereas the latter drug was used 
as an internal standard for the experiments with pentobarbital. 
A glass column filled with 5% SE-30 on Diatoport S 60-80 mesh 
was used. The oven temperature was 190° - 200 C. 
RESULTS 
Intact rats 
In the intact rat there was a rapid fall in the concentra-
tion of both barbiturates immediately after the i.v. injection 
of the drug. The decline lasted approximately 5 minutes. After 
this initial drop, the drug concentration decreased more 
slowly. This second phase, however, was more steep with hexo-
barbital than with pentobarbital. Two characteristic examples 
are presented in figure 3-1 and figure 3-2. When the blood 
concentration is plotted as function of time on a semi-
logarithmic scale, the resulting curve is essentially biphasic. 
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Figur· 3-3 
S.0 10.0 IS.O 
TIHE (MINUTES) 
30.0 
Perfusion fluid concentration егвив timet following addition 
of sodium Eexobarbital (7 mg of the free acid; experiment 
number 45). The points represent individual experimental 
values, whereas the line is the best fit aooording to the 
computer program for a mono-exponential curve mentioned in 
chapter 2. 
ІЯ.О 1Я.0 
Figure 3-4 TIHE WINUTES) 
Perfusion fluid concentration versus time, following addition 
of sodium Pentobarbital (4.56 mg of the free acid; experiment 
number 16). The points represent individual experimental 
values, whereas the line is the best fit according to the 
computer program for a mono-exponential curve mentioned in 
chapter 2.
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The blood curve may therefore be described by two exponential 
terms according to the open two compartment kinetic models. 
The decrease of the concentration in the first phase for both 
barbiturates corresponds to a half-life of 1 - 2 minutes. On 
the other hand the decrease in the second phase was 14 
minutes for hexobarbital and 62 minutes for pentobarbital. 
The pharmacokinetic parameters, calculated in the intact rat, 
are presented in table 3-5 and table 3-6. The mean elimination 
clearance constant of hexobarbital in the intact rat is 9.9 
ml/min (equivalent to 47 ml/min«kg body weight). For pento-
barbital the value was lower, 2.7 ml/min (equivalent to 10.7 
ml/min«kg body weight). 
The mean value of the volume of the central compartment 
(V.) was 490 ml/kg for hexobarbital and 445 ml/kg for pento-
barbital. The volume of the central compartment varied over 
a wide range (231 - 766 ml/kg for hexobarbital and 146 - 682 
ml/kg for pentobarbital). The distribution between the central 
and the peripheral compartment was very rapid. The clearance 
constant of distribution between the two compartments was 91 
ml/min-kg for hexobarbital and 67.8 ml/min«kg for pentobarbital. 
The total fictive volume of distribution or V- was 819 ml/kg 
for hexobarbital and 875 ml/kg for pentobarbital. 
The ieolated perfused liver 
The blood concentration of the drugs in the perfused rat 
liver decreased exponentially according to the one compartment 
model (see figure 3-3 and figure 3-4). The decrease of the 
perfusate concentration corresponds to a half-life of 7.5 
minutes for hexobarbital and to a half-life of 34 minutes 
for pentobarbital. The rate ôf metabolism of hexobarbital was 
much more rapid than the rate of metabolism of pentobarbital. 
The metabolic clearance constant and the other kinetic para-
meters are shown in table 3-7 and table 3-8. The volume of 
distribution of hexobarbital in the perfusion fluid was 103 
ml and the volume of pentobarbital was 109 ml. 
The amount excreted in the bile was less than the 10% 
of the total amount eliminated during the duration of the 
experiment. 
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DISCUSSION 
A marked difference is found in the rate of elimination 
of hexobarbital and pentobarbital in the intact rat. The 
elimination clearance constant of hexobarbital is much higher 
than the clearance constant of pentobarbital. Hexobarbital 
has а к . of 6 - 12 ml/min (30 - 65 ml/min»kg) and pento­
barbital 1.9 - 2.7 ml/min (8 - 12 ml/min·kg). The same 
difference was found in the metabolic clearance constant of 
the isolated perfused rat liver. The values of the metabolic 
clearance constant in the liver closely agree with the values 
of the elimination clearance constant in the intact animal. 
Furthermore, for the rats that have been used in both 
experimental conditions it was found that the clearance 
constants of elimination and metabolism are very similar. 
See table 3-5 and 3-8. 
These findings may suggest that there are no important 
routes of elimination other than metabolism in the liver. 
The other possible route of drug elimination is the renal 
excretion, but it seems unlikely for hexobarbital and 
pentobarbital to be excreted by the kidneys because both 
have a high pK , compared to the pH of blood and urine. They 
also show a rather high degree of liposolubility (Kakemi e.a. 
1967). Under such conditions they should be almost completely 
reabsorbed in the tubules of the kidneys. The value of k.^ 
shows that the distribution process between the central and 
peripheral compartment occurs very quickly with both 
barbiturates. The fictive volume of distribution or Vf of 
hexobarbital and pentobarbital (819 ml/kg and 875 ml/kg 
respectively) indicates that both barbiturates are even 
distributed in the total body water (Domínguez, 1950). 
The results of the present experiments do not agree with 
some other reports on hexobarbital: Quinn (Quinn e.a., 1958) 
reports a half-life of 140 minutes and Kuhlman (Kuhlman e.a., 
1970) reports a half-life of 70 - 100 minutes. Both values 
were calculated from average data. One explanation for the 
differences may be that these values were calculated using 
female rats; and in the present experiment only male rats 
were used. Sex differences in the drug metabolism capacity of 
the rat are well known (Kato and Takanaka, 1967) . Quinn - in 
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the same paper - reports a difference in the hexobarbital 
sleeping time for female and male rats (90 minutes for 
females and 22 minutes for males). 
The parameters calculated for pentobarbital agree with 
the values reported by Kato and Takanaka (Kato and Takanaka, 
1967). From their average data а к . of 8 - 15 ml/min-kg and 
a half-life of 46 - 81 minutes in male rats may be calculated. 
In other species hexobarbital,also behaves as a short 
acting barbiturate. The half-life in larger animals is longer 
than in the rat (60 min. rabbit; 260 min. dog; 360 min. man) 
(Quinn et al, 1958), but in a particular species it is shorter 
when compared with the half-life of other barbiturates. 
For pentobarbital, in man, a half-life of approximately 
21 hrs (Held e.a., 1970) and 36 hrs (Brodie e.a., 1953) is 
reported. From the paper of Brodie, a clearance constant of 
40 ml/min may be calculated. In this report the weight of the 
subject is not given and therefore it is not possible to 
normalize the clearance constant of elimination as a fraction 
of the body water. Nevertheless, when a "standard" weight of 
60 - 90 kg is assumed, the clearance constant of elimination 
is expressed as a fraction of the body weight in kg is much 
lower than in the rat. 
From the experiments of hexobarbital and pentobarbital 
in the intact rat and the isolated perfused rat liver it may 
be concluded that the duration of action of both drugs is 
largely dependent on the rate of metabolism. It should, 
however, be realized that tolerance to the hypnotic action 
of barbiturates develops rapidly, sothat the duration of 
action also depends on the degree of tolerance. 
SUMMARY 
The kinetics of distribution and elimination of hexo­
barbital and pentobarbital were studied in the intact rat and 
in the isolated perfused rat liver. 
In the rat, both drugs are eliminated according to two 
compartment kinetics while in the perfused liver they are 
eliminated according to single compartment kinetics. 
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Hexobarbltal was eliminated very quickly in both 
preparations and at the same rate. Pentobarbital was eliminated 
more slowly but also with the same rate in both preparations. 
It has been concluded that both barbiturates were 
eliminated almost completely by metabolism in the liver. 
The present results were compared with the results in some 
other species. In man and other animal species, hexobarbltal 
and pentobarbital have a longer half-life than in the rat. 
The main reason for this difference appears to be the 
differences in the value of the elimination clearance constant. 
RESUMEN 
En el presente capitulo se describe la cinética de la 
distribución y eliminación de los barbitûricos hexobarbltal y 
pentobarbital en la rata y en el hígado de rata aislado y 
perfundido. 
Ambos barbitûricos fueron eliminados en la rata de 
acuerdo al modelo cinético abierto de dos compartimientos. 
Se calcularon los parámetros cinéticos correspondientes a 
cada una de las drogas en la rata (tabla 3-5 y tabla 3-6) 
y en el hígado de rata aislado y perfundido (tabla 3-7 y 
tabla 3-8). Hexobarbltal es eliminado muy rapidamente y 
con la misma velocidad en ambas preparaciones. Pentobarbital 
por otra parte, fue eliminado en forma más lenta pero tam-
bién con una velocidad similar en ambas preparaciones. Se 
puede concluir que hexobarbltal y pentobarbital son 
eliminados casi totalmente por medio de inactivación 
metabòlica en el hígado. 
Los resultados obtenidos en estos experimentos fueron 
comparados con similares resultados en otras especies. En 
el hombre ambos barbitûricos tienen una hemivida mucho más 
larga que en la rata. Esto se debe principalmente a que la 
constante de aclaramiénto de eliminación, normalizada de 
acuerdo al peso, es mayor en la rata que en el hombre. 
60 
LITERATURE 
BRODIE, B.B., BURNS, J.J., MARK, L.C., LIEF, P.A., BERNSTEIN,E. 
and E.M. PAPPER: The rate of pentobarbital in man and 
dog and a method for its estimation in biological 
material. J. Pharm. Exp. Ther. 109, 26 (1953). 
DOMÍNGUEZ, R.: Kinetics of elimination, absorption and volume 
of distribution in the organism. In: Classer, О. ed.: 
Medical Physics. Vol. II. The Year Book Publishers, 
Inc., Chicago (1950). 
HELD, H. VON OLDERSHAUSEN, H.F. and H. REMER: Der Abbau von 
Pentobarbital bei Leberschäden. Klin. Wschr. 39, 
565 (1970). 
KAKEMI, К., ARITA, T., HORI, R. and R. KONISHI: Absorption and 
excretion of drugs. XXX. Absorption of barbituric 
acid derivatives from rat stomach. Chem. Pharm. Bull. 
15, 1534 (1967). 
KATO, R. and A. TAKANAKA: Effect of starvation on the in vivo 
metabolism and effect of drugs in female and male 
rats. Jap. J. Pharmacol. 12, 208 (1967). 
KUHLMANN, К., ODUAH, N. and Η. COPER: Über die Wirkung von 
Barbituraten bei Ratten verschiedenen Alters. 
Naunyn.Schmiedebergs Arch. Pharmak. 265, 310 (1970) . 
MARTINDALE, W.: Extra Pharmacopaeia, ed. R.C. Todd. The 
Pharmaceutical Press, London (1967). 
McARDLE, C : Formulation and presentation of the barbiturates. 
In: Matthew , H. ed. Acute barbiturate poisoning. 
Excerpta Medica Foundation, Amsterdam (1971). 
PARKE, D.V.: Biochemistry of the barbiturates. In: Matthew, 
H. ed. Acute barbiturate poisoning. Excerpta Medica 
Foundation, Amsterdam (1971) . 
QUINN, G.P., AXELROD, J. and B.B. BRODIE: Species, strain and 
sex differences in metabolism of hexobarbitone, 
aminopirine, antipirine and aniline. Biochem. 
Pharmacol. 1, 152 (1958). 
61 
SHARPLESS, S.К.: Hypnotics and sedatives. I. The barbiturates. 
In: Goodman, L.S. and Gilman, A. ed. The pharmacolo­
gical basis of therapeutics. The MacMillan Company, 
New York (1970). 
MARK, L.C.: Archaic classification of barbiturates. Clin. 
Pharmacol. Ther. 10, 2Θ7 (1969). 
62 
Exp 
Time 
(min) 
1.5 
3 
5 
10 
15 
24 
30 
40 
». 1. 
Cone. 
(mg/1) 
120.0 
84.0 
72.8 
50.0 
34.4 
23.0 
17.3 
9.5 
Exp 
Time 
(min) 
1.5 
3.5 
6.5 
11 
16 
25.5 
39.5 
>. 2. 
Cone. 
(mg/1) 
89.0 
68.0 
53.0 
38.0 
26.4 
19.2 
8.6 
Exp. 3. 
Time 
(min) 
1 
3 
5 
9 
15 
25 
30 
41 
Cone. 
(mg/1) 
81.6 
70.4 
64.0 
40.0 
37.0 
27.6 
22.0 
13.6 
Exp. 4. 
Time 
(min) 
1 
3 
5 
10 
15 
19.5 
30 
41 
Cone. 
(mg/1) 
114.0 
81.0 
59.0 
38.4 
23.1 
15.9 
8.0 
3.0 
Exp. 5. 
Time 
(min) 
1 
3 
5 
10 
15 
20 
40.5 
Cone. 
(mg/1) 
119.0 
73.6 
60.8 
41.5 
35.0 
24.0 
6.4 
Exp. 6. 
Time 
(min) 
1 
3 
5 
10 
15.5 
25.5 
30.5 
Cone. 
(mg/1) 
200.0 
103.0 
75.6 
53.8 
44.2 
30.0 
23.9 
ω 
TABLE 3-2 
Pentobarbital in the intact rat. 
Experimental data in oaee of the sodium salt. 
Exp. 7. 
Time 
(min) 
2 
4 
7 
21 
31 
65 
125 
175 
Cone. 
(mg/1) 
41.5 
35.5 
31.3 
24.6 
22.0 
11.4 
7.0 
4.2 
Exp. 8. 
Time 
(min) 
1 
3 
5 
18.5 
26.5 
60.5 
122.5 
172.0 
Cone. 
(mg/1) 
36.6 
30.6 
27.0 
23.0 
17.0 
14.0 
7.7 
5.0 
Exp. 9. 
Time 
(min) 
2 
6 
21.5 
39.5 
60.5 
124 
181 
Cone. 
(mg/1) 
46.3 
39.5 
25.7 
23.0 
16.6 
9.0 
5.1 
Exp. 10. 
Time 
(min) 
1.5 
3.5 
17 
40.5 
60 
122 
180 
Cone. 
(mg/1) 
49.0 
45.0 
27.4 
18.6 
15.0 
7.4 
3.8 
Exp. 11. 
Time 
(min) 
1.5 
2.8 
5 
16.5 
38 
64 
126 
186 
Cone. 
(mg/1) 
57.0 
39.0 
26.4 
20.6 
14.7 
11.9 
4.8 
2.0 
Exp. 12. 
Time 
(min) 
1 
3 
6 
18 
32 
63 
120 
179 
Cone. 
(mg/1) 
84.0 
35.2 
28.0 
23.9 
17.5 
14.8 
5.7 
2.6 
Exp. 13. 
Time 
(min) 
1.5 
3.5 
5 
14 
29 
61 
115 
182 
Cone. 
(mg/1) 
44.0 
34.2 
29.6 
24.0 
21.0 
13.1 
5.5 
1.8 
TABLE 3-3 
Bexobarbital in the ieolated perfused rat liver. 
Experimental data after the addition of the вodium aalt in the 
perfusion medium. 
Perf. No. 16 
Time 
min. 
5 
15 
30 
60 
120 
Cone. 
mg/1. 
44.6 
35.4 
25.3 
13.2 
2.7 
Perf. No, 17 
Time 
min. 
5 
15 
30 
60 
120 
Cone. 
mg/1. 
27.0 
27.5 
19.7 
10.3 
2.7 
Perf. No. 18 
Time 
min. 
5 
15 
30 
60 
120 
Cone. 
mg/1. 
. 39.3 
32.3 
23.2 
14.6 
4.8 
Perf. No. 20 
Time 
min. 
5 
15 
30 
60 
120 
Cone. 
mg/1. 
42.0 
27.6 
25.0 
12.4 
3.6 
TABLE 3-4 
Pentobarbital in the isolated perfused rat liver. 
Experimental data after the addition of the sodium salt in the 
perfusion medium. 
Perf. No. 38 
Time 
min. 
6 
10 
15 
20 
25 
Cone. 
mg/1. 
47.4 
25.8 
18.0 
10.8 
4.0 
Perf. No. 40 
Time 
min. 
6 
10 
15 
20 
Cone. 
mg/1. 
25.0 
16.0 
11.0 
5.0 
Perf. No. 43 
Time 
min. 
4 
6 
10 
15 
Cone. 
mg/1. 
48.9 
43.1 
34.6 
22.0 
Perf. No. 45 
Time 
min. 
6 
10 
15 
20 
25 
Cone. 
mg/1. 
41.5 
27.6 
22.4 
13.4 
8.6 
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TABLE 3-5 
Hexobarbital гп the intact rat. 
Pharmacokinetic data and parameter вt calculated from blood concentration curvee. 
Experimental 
Number 
Dose (mg/kg) 
Weight (g) 
A1 (mg/1) 
A 2 (mg/1) 
τ 1 (min) 
τ 2 (min) 
tj (min) 
2 
k 1 2 (mi/min.kg) 
к
 1 (mi/min,kg) 
к . (ml/min) 
V1 (ml/kg) 
V f (ml/kg) 
73,5 
200 
юз 
8U 
1,6 
19 
13 
99 
из 
8.5 
393 
721 
1 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
U5 
6 
0,7 
1 
0,7 
Ul 
1 
0,2 
99 
U1 
73,5 
200 
750 
61 
3.U 
20 
1U 
5U 
52 
10,U 
66U 
956 
2 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
13 
9 
1,7 
2 
1 
33 
2 
0,3 
93 
56 
73,5 
200 
36 
60 
3 
29 
20 
67 
UO 
8,0 
766 
1085 
3 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
16 
1 1 
3 
5 
3 
70 
2 
0,5 
139 
109 
U 
73,5 
200 
6U + 
77 + 
2,5 * 
12,5 + 
8,7 + 
53 ; 
65 + 
12,8 + 
522 + 
727 + 
iU 
6 
0,8 
0,5 
0.3 
2U 
1 
0,3 
5U 
26 
5 
73,5 
200 
119 + 
83 + 
0,9 + 
15,2 + 
11,0 + 
186 + 
51 Í 
10,3 + 
36U + 
758 + 
67 
U 
0,5 
0,6 
o.u 
88 
1 
0,3 
125 
37 
6 
73,5 
200 
238 + 
81 + 
1,5 + 
25 + 
17 + 
87 + 
30,6 + 
6,12 + 
231 + 
668 + 
11 
2 
0,08 
7 
5 
3 
0,3 
0,06 
9 
13 
TABLE 3-7 
Hexobarbital in the iaolated perfused rat liver. 
Kinetic data and parameters calculated from blood concentration 
curvee. 
P e r f u s i o n number 
Dose (mg) 
C 0 (mg/1) 
τ (min) 
t ^ (min) 
V f (ml) 
к - (ml/min) 
38 
10 
99 + 19 
8 . 1 + 0.8 
5.6 + 0.5 
101 + 20 
1 2 + 1 
40 
5 
5 0 + 8 
8 .9 + 0.9 
6 .2 + 0.6 
99 + 15 
1 1 . 1 + 0.8 
43 
7 
67 + 4 
14 + 1 
9 . 6 + 0 .8 
105 + 6 
7 . 5 + 0 . 3 
45 
7 
67 + 6 
12.4 + 0.8 
8 .6 + 0 . 5 
105 + 9 
8 . 5 + 0.4 
TABLE 3-8 
Pentobarbital in the isolated perfused rat liver. 
Kinetic data and parameters calculated from blood concentration 
curves. 
P e r f u s i o n number 16 
Dose (mg) 
C 0 (mg/1) 
τ (min) 
t , (min) 
V f (ml) 
к , (ml/min) 
4.56 
52 + 2 
41 + 1 
2 8 . 1 + 0.8 
87 + 4 
2.16 + 0.06 
17 (a) 
4 .56 
30 + 2 
48 + 3 
33 + 2 
134 + 10 
2.7 + 0 .1 
18 (b) 
4 .56 
39 + 25 
57 + 16 
40 + 11 
108 + 3 
1.96 + 0.04 
20 
4.56 
43 + 3 
49 + 3 
34 + 2 
107 + 7 
2 . 2 + 0 . 1 
(a) The liver from experiment 17 is from rat number 7 
(b) The liver from experiment 18 is from rat number 8 
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TABLE 3-6 
Pentobarbital in the intact vat. 
Pharmacokinetic data and parameters, calculated from blood concentration curvee. 
Experimental 
Number 
Dose (mg/kg) 
Weight (g) 
A1 (m¿/l) 
A 2 (mg/1) 
τ. (min) 
'τ 2 (min) 
t! (min) 
к ^ (ml/min.kg) 
к . (ml/min.kg) 
к . (ml/min) 
V 1 (ml/kg) 
V f (ml/kg) 
27.5 
2l»0 
22 
18 
2k 
119 
82 
7. 
10. 
2. 
682 
1017 
7 
+ 
+ 
+ 
+ 
+ 
9+ 
1 + 
U + 
7 
8 
12 
36 
25 
3. 
0. 
0. 
+ 1U0 
+ U6 
7 
6 
1 
26.1 
230 
16 
2U 
3. 
109 
75 
6U 
9. 
2. 
6hk 
1037 
7 
7 
8 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
23+ 
+ 
+ 
5 
2 
1. 
8 
6 
38 
0. 
0. 
86 
57 
9 
k 
09 
2 7 . !< 
350 
21 
32 
7. 
98 
68 
21 
8. 
2. 
522 
789 
9 
+ 
+ 
0 + 
+ 
+_ 
+ 
35+ 
92 + 
+ 
+ 
h 
2 
3. 
5 
3 
13 
0. 
0. 
U7 
28 
1 
19 
07 
10 
28.1 
320 
2U.6 + 
29.3 + 
8.U + 
88.2 + 
61.1 + 
20.8 + 
9.83 + 
3.1 U+ 
510 + 
809 + 
0.7 
O.U 
0.6 
0.9 
0.6 
1.7 
0.05 
0.02 
6 
7 
1 1 
26.3 
228 
90 + 
26 + 
1.5 + 
7U + 
51 ± 
109 + 
12.9 + 
2.9U + 
227 + 
890 + 
22 
1 
0. 
2 
1 
9 
0. 
0. 
U 
35 
.3 
,3 
07 
27.2 
220 
157 
30 
0. 
7U 
51 
118 
11 . 
2. 
IU6 
802 
12 
\ 
+ 
+ 
9 + 
+ 
+ 
+ 
6 + 
55 + 
+ 
+ 
52 
2 
0. 
3 
2 
1U 
0. 
0. 
Ui 
uu 
2 
1 
13 
26.U 
218 
37 
32 
1.U 
6U 
UU 
13U 
12.6 
+ 
+ 
+ 
+ 
+ 
+ 
^ 
03 2.75+ 
382 
787 
+ 
+ 
19 
1 
0 
2 
1 
57 
0 
0.0 
29 
111 
с 
c-c-c-c^.c-c с=с-с с-с 
0=^=0 0=^=0 
К II 
О о 
bu toba rbi ta I a pro ba r bita I 
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CHAPTER Ί 
KINETICS OF ELIMINATION OF APROBARBITAL AND BUTOBARBITAL IN 
THE INTACT RAT AND THE ISOLATED PERFUSED RAT LIVER 
According to the usual classification of barbiturates (see 
Introduction), aprobarbital and butobarbital are ranked as 
intermediate acting barbiturates (McArdle, 1971; Martindale, 
1969; Sharpless, 1970; Mark, 1963). Butobarbital is, to a 
large extent, therapeutically used as an intermediate acting 
hypnotic. On the other hand, aprobarbital is used as a sedative 
on a small scale in most countries, but more extensively in 
Scandinavian countries (Mark, 1969). 
In rat and other small laboratory animals, these drugs 
show an intermediate action when compared with other barbi­
turates. But this action is much shorter than in man. In male 
rats, the sleeping time of 56 mg/kg of aprobarbital is 160 
minutes (Yih, 1970), whereas in man the same dose produced an 
unconscious state, similar to the "sleep" of the rat that 
lasted approximately 130 hours (Lous, 1954). 
In order to obtain information on the relative role of 
distribution and metabolism for the duration of hypnotic action 
aprobarbital and butobarbital were studied both in the intact 
rat and in the isolated perfused rat liver. 
METHODS AND MATERIALS 
Experimental methode 
Male wistar rats were used in the intact rat and in the 
perfused liver experiments. 
Five animals were injected i.v. with 7.4 - 15 mg (equi­
valent to 35.5 - 75 mg/kg) of aprobarbital and four animals 
with 10 - 15 mg (equivalent to 50 - 75 mg/kg) of butobarbital. 
Blood samples were taken at regular time intervals for the 
determination of the drug content (see table 4-1 and table 4-2) . 
From the concentration of the drug in the blood as a function 
of time after administration, pharmacokinetic parameters were 
calculated (see chapter 1 and 2). 
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Figure 4-1 
100.0 
TIME (MIN) 
Blood о one entrât ion versus time, following intravenous 
administration of sodium Aprobarbital (37.S mg/kg of the 
free acid; rat number 20). The points represent individual 
experimental values, whereas the line is the best fit 
aeoording to the computer program for a biexponential curve 
mentioned in chapter 2. 
Blood concentration versus time, following intravenous 
administration of sodium Butobarbital (75 mg/kg of the free 
acid; rat number 17). The points represent individual 
experimental values, whereas the line is the best fit 
according to the computer program for a biexponential curve 
mentioned in chapter 2. 
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The isolation and perfusion of the liver was done as 
described in chapter 2. In four perfusions 5 - 7 mg of 
aprobarbital, and in six perfusions 5 - 8 mg of butobarbital 
were added to 100 ml of perfusion fluid. Samples were taken 
at regular time-intervals for determination of the drug 
content (see table 4-3 and table 4-4). Kinetic parameters 
were calculated from the concentration of the drug in the 
perfusate as a function of time after administration (see 
chapter 1 and 2). 
Drugs 
The free acid forms of aprobarbital and butobarbital were 
dissolved in sterile water with an equimolecular amount of 
NaOH to obtain a solution of 20 mg/ml. Therefore, the final 
volume injected to the animals or added to the perfusate was 
in the order of 0.5 ml but always smaller than one ml. 
Analytical methode 
The drug content of the samples was determined with the 
gas-chromatograph as it was described in chapter 2. Hexo-
barbital was used as internal standard. The column used was 
packed with 5% SE-30 on Diatoport S 60/80. The oven tempera-
ture was 200° C. 
RESULTS 
Intact rate 
Following i.V. injection of aprobarbital and butobarbital, 
there was a rapid fall in the blood concentration over a period 
of approximately five minutes, whereafter the blood concentra-
tion decreased far more slowly over an interval of at least two 
hours. This may be seen for aprobarbital in figure 4-1 and for 
butobarbital in figure 4-2. The blood concentration curves 
plotted on a semilogarithmic scale are essentially biphasic. 
Therefore, the blood curve may be described by two exponential 
terms according to the open two compartment kinetic model. 
The decrease in the blood concentration of both barbiturates 
in the first phase corresponds to a half-life of about one 
minute, whereas the decrease in the second phase corresponds to 
a mean half-life of 124 minutes (81 - 211 minutes) for buto-
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Figure 4-3
 Т]МЕ циШіЕа 
Perfusion fluid concentration vereue time, following addition 
of Bodium Aprobarbital (S mg of the free acid; experiment 
number SO). The pointe represent individual experimental 
valuest whereas the line is the best fit according to the 
computer program for a mono-exponential curve mentioned in 
chapter 2. 
so.o 
чо.о 
50.0 60.0 70.0 
Figure 4-4 TIME MINUTES) 
Perfusion fluid concentration vereue time, following addition 
of sodium Butobarbital (S mg of the free acid; experiment 
number 52). The points represent individual experimental 
values, whereas the line is the best fit according to the 
computer program for a mono-exponential curve mentioned in 
chapter 2. 
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barbital and 173 minutes (70 - 292 minutes) for aprobarbital. 
The pharmacokinetic parameters, calculated from the 
individual experiments, are presented in table 4-5 and table 
4-6. In intact rats the elimination clearance constant for 
butobarbital was found to be 0.48 - 1.2 ml/min and for apro-
barbital 0.3 - 1.3 ml/min. The mean value for both drugs was 
0.9 ml/min. When normalized to the body weight, butobarbital 
has a clearance constant of 2.39 - 6.2 ml/min«kg (mean =4.5 
ml/min kg) and aprobarbital of 1.5 - 6.4 ml/min»kg (mean = 
4.1 ml/min kg). The mean value of V was 273 ml/kg for buto-
barbital and 228 ml/kg for aprobarbital and varied over a 
wide range (133 - 409 ml/kg for butobarbital and 71 - 431 
ml/kg for aprobarbital). There was also a wide variation in 
the value of Vf, 499 - 850 ml/kg (mean = 702 ml/kg) for buto-
barbital and 499 - 1290 ml/kg (mean = 884 ml/kg) for apro-
barbital. The mean value of the clearance constant of distri-
bution between the compartments was 82 ml/min kg for buto-
barbital and 164 ml/min kg for aprobarbital. Here again the 
values varied over a wide range (66.9 - 124 ml/min kg for 
butobarbital and 77.6 - 240 ml/min kg for aprobarbital). 
Liver perfusion 
In the isolated perfused rat liver aprobarbital and buto-
barbital disappeared according to single compartment kinetics. 
See figure 4-3 and figure 4-4 The disappearance of butobarbital 
was faster than the disappearance of aprobarbital. This may be 
seen from the half-life values, which are 114 minutes for buto-
barbital and 251 minutes for aprobarbital. 
From the kinetic data of these in vitro experiments, it may 
be seen that the average metabolic clearance constant of buto-
barbital is about 0.6 ml/min for liver of rats of 200 g body 
weight (see table 4-8). The metabolic clearance of aprobarbital 
is about 0.3 ml/min (see table 4-7). For both drugs, the amount 
excreted into the bile is less than 10 pet of the amount 
eliminated during the duration of the experiment. The average 
volumes of distribution are 102 ml for butobarbital and 95 ml 
for aprobarbital. The volume of distribution in the perfusion 
experiments are therefore similar for both drugs. 
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DISCUSSION 
The rate of elimination of butobarbital and aprobarbital 
in the intact Wistar rat is of the same order of magnitude. 
They have an average elimination clearance constant of 0.9 
ml/min (range 0.48 - 1.2 ml/min for butobarbital and 0.3 -
1.3 ml/min for aprobarbital). 
The metabolic clearance constant of butobarbital in the 
isolated rat liver is in the order of magnitude of the total 
clearance in the intact rat (average 0.6 ml/min, range 0.6 -
0.7 ml/min). Aprobarbital, on the other hand, has a metabolic 
clearance constant in the liver that is lower than the total 
clearance constant in the intact rat. 
It must be concluded that butobarbital is eliminated 
predominantly by means of liver metabolism but that apro-
barbital is also eliminated via other routes. Aprobarbital, 
as it is evident from its partition coefficient (chloroform-
water) , has a low degree of liposolubility when compared with 
butobarbital (Yih, 1970). This Implies that renal excretion 
may be a major route of elimination in the intact rat. It has 
been shown that aprobarbital, as such, is excreted through 
the kidneys in dog and in man (Stewart and Stolman, I960; 
Myschetsky and Lassen, 1971; Lous, 1954 b). 
As can be seen from the values of the distribution 
clearance of both barbiturates, the distribution between the 
two compartments is very rapid. After the process of 
distribution is completed, both barbiturates show approximately 
the same volume of distribution. Butobarbital has an average V^ 
of 702 ml/kg (range 499 - 830 ml/kg) and aprobarbital of 884 
ml/kg (range 499 - 1290 ml/kg). These values correspond 
approximately to the volume of the body water (Domínguez, 1950). 
The same can be said from the perfusion experiments. Here the 
volume of distribution is almost equal to the volume of the 
perfusion fluid. 
The biological half-life of butobarbital after oral admini-
stration in man is 30 - 40 hours (Lamers, 19б4) . Since the half-
life in man is very long in comparison to the time constant for 
absorption, these oral data may be analyzed by single compart­
ment kinetics. From the experiments of Lamers, it may be 
calculated that the clearance constant of elimination of butô-
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barbital is in the order of 0.5 ml/min«kg body weight. In the 
rat, the elimination clearance is 4 ml/min-kg, sothat the 
clearance is about 10 times larger. On the other hand the 
volume of distribution is approximately the same in both 
species. In the rat it is 702 ml/kg and in man it is 810 ml/ 
kg. 
Aprobarbital also shows a slower elimination in man than 
in the rat. From the results reported by Lous (Lous, 1954 b) 
a half-life of 28 hours and a clearance constant of 0.3 ml/ 
min»kg body weight may be calculated. Here again, the 
clearance constant in the rat (4 ml/min«kg) is 10 times 
larger than in man. The volume of distribution calculated from 
this paper is equal to 500 ml/kg. This value is smaller than 
in the rat (884 ml/kg). 
Comparing the pharmacokinetics of butobarbital and apro-
barbital in man and rat, it can be seen that both barbiturates 
have a longer half-life in man than in the rat. This difference 
is mainly due to the difference in the clearance constant; it 
is much higher in the rat than in man. This relation is more 
easily seen with butobarbital than with aprobarbital. Apro-
barbital has, in man, a clearance smaller than butobarbital, 
but it also has a smaller volume of distribution. It is there-
fore understandable that the resulting half-life is approxi-
mately the same for both barbiturates. 
SUMMARY 
The kinetics of distribution and elimination of aprobar-
bital and butobarbital were studied in the intact rat and in 
the isolated perfused rat liver. Kinetic parameters were calcu-
lated from the blood concentration curves. In the intact rat both 
drugs are eliminated at the s cime rate, whereas in the isolated 
perfused rat liver, butobarbital is eliminated more rapidly 
than aprobarbital. It is concluded that, in addition to 
metabolism in the liver, aprobarbital is also eliminated by 
means of other routes. As a probable route may be considered 
the kidney. Butobarbital is eliminated mainly by metabolism in 
the liver. 
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The results, obtained in the rat, are compared with the 
kinetics of the same drugs in other species. In man both drugs 
have a longer half-life than in the rat. This difference is 
mainly due to a difference in the value of the elimination 
clearance constant in rat and man. 
RESUMEN 
En el presente capitulo se describe la cinética de la 
eliminación y distribución de los barbitúricos butobarbital y 
aprobarbital. 
Se construyeron curvas de la concentración en sangre en 
función del tiempo. En base a estas curvas se calcularon los 
parámetros cinéticos correspondientes a cada una de las 
drogas en la rata (tabla 4-5 y tabla 4-6) y en el hígado de 
rata aislado y perfundido (tabla 4-7 y tabla 4-8). 
En la rata, butobarbital y aprobarbital son eliminados 
con la misma velocidad. En el hígado aislado y perfundido, 
butobarbital es eliminado con la misma velocidad que en la rata. 
Aprobarbital, por otra parte, es eliminado en forma mucho más 
lenta. 
Se concluyó que aprobarbital es eliminado en la rata por 
medio de otras rutas además del metabolismo en el hígado. La 
más probable de estas rutas es la renal. Butobarbital por el 
contrario es aparentemente casi totalmente eliminado en el 
hígado por medio de inactivación metabòlica. 
Los resultados obtenidos en estos experimentos en la rata 
fueron comparados con los resultados en otras especies. En el 
hombre ambas drogas tienen una hemivida más larga que en la 
rata. Esta diferencia se debe principalmente al valor de la 
constante de aclaramiento total que en la rata es relativa-
mente mayor que en el hombre. 
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1 
2 
10 
20 
60 
90 
97 
80 
65 
67 
54 
52 
2.25 
4 
5 
25 
35 
45 
60 
90 
115 
87 
92 
74 
69 
64 
57 
42 
2 
4 
6 
10 
35 
45 
90 
134 
113 
88 
85 
77 
69 
54 
1.50 
3.25 
4 
10 
30 
60 
90 
281 
191 
151 
129 
112 
81 
66 
TABLE 4-2 
Aprobarbital in the intact vat. 
Experimental dat in aase of i.V. injection of the sodium salt. 
Exp. 18 
Time 
(min) 
1 
2 
3 
10 
22 
36 
42 
60 
76 
121 
Cone. 
(mg/1) 
115 
87 
70 
52 
59 
54 
44 
37 
36 
35 
Exp. 19 
Time Cone. 
(min) (mg/1) 
0.5 
1 
2 
3 
6 
10 
30 
60 
444 
304 
134 
129 
105 
92 
65 
63 
Exp. 20 
Time 
(min) 
0.50 
1 
2.75 
4.75 
20 
29.25 
59.25 
89.25 
Cone. 
(mg/1) 
101 
74 
56 
49 
44 
46 
42 
36 
Exp. 21 
Time 
(min) 
1 
2 
3 
5 
20 
32 
44 
75 
91 
120 
Cone. 
(mg/1) 
98 
62 
45 
47 
43 
39 
35 
33 
29 
29 
Exp. 22 
Time 
(min) 
1 
2 
3 
10 
20 
48 
61 
76 
84 
120 
Cone. 
(mg/1) 
208 
141 
99 
94 
90 
88 
75 
75 
66 
79 
3 
ital in the isolated perfused rat liver. 
ntal data after the addition of the sodium salt in 
usion medium. 
o. 37 
Cone. 
(mg/l) 
67 
59 
55 
47 
o. 54 
Cone. 
(mg/l) 
44 
42 
34 
30 
Perf. No. 52 
Time 
(min) 
10 
20 
30 
40 
50 
60 
Cone. 
(mq/1) 
46 
43 
39 
38 
35 
34 
Perf. No. 55 
Tine 
(min) 
10 
20 
40 
60 
80 
Cone. 
(mg/l) 
47 
46 
40 
36 
26 
Perf. No. 53 
Tine 
(min) 
10 
20 
40 
60 
80 
Cone. 
(mg/l) 
52 
42 
40 
32 
34 
Perf. No. 56 
Tine 
(nin) 
10 
20 
40 
60 
80 
Cone. 
(mg/l) 
44 
43 
37 
36 
30 
4 
ital in the isolated perfused rat liver. 
ntal data after the addition of the sodium salt in 
usion medium. 
o. 48 
Cone. 
mg/l) 
63 
65 
64 
62 
56 
55 
Perf. No. 49 
Time 
(nin) 
10 
20 
30 
40 
50 
60 
Cone. 
(mg/l) 
51 
51 
52 
55 
44 
46 
Perf. No.50 
Time 
(nin) 
10 
20 
30 
40 
50 
60 
Cone. 
(mg/l) 
52 
49 
44 
43 
41 
43 
Perf. No. 51 
Tine 
(nin) 
10 
20 
30 
40 
50 
60 
Cone. 
(mg/l) 
55 
52 
46 
51 
50 
48 
79 
TABLE 4-5 
Butobarbital in the intact vat. 
Pharmaookinetia data and parameters calculated from blood concentration curvea 
Exp. number 
Dose (mq/kq) 
Weicht (q) 
A 1 (nq/l) 
A 2 (mq/1) 
τ 1 (min) 
τ 2 (min) 
t^ (min) 
к.- (ml/min.kq) 
к - (ni/min.kq) 
k
e l (mi/min) 
V 1 (ml/ka) 
V f (ml/kn) 
50 
200 
54 
68 
1. 
304 
211 
124 
2. 
0. 
409 
725 
14 
+ 
+ 
4 + 
+ 
+ 
+ 
4 + 
48+ 
+ 
+ 
9 
2 
0.4 
57 
40 
33 
0.4 
0.08 
29 
25 
15 
75 
200 
95 
88 
1. 
136 
94 
129 
6. 
1. 
409 
830 
+ 
+ 
6
 ± 
+ 
+ 
+ 
2 + 
2 + 
+ 
+ 
19 
4 
0.4 
14 
10 
30 
0.4 
0.08 
45 
33 
16 
75 
200 
427 
94 
0. 
157 
109 
124 
4. 
1. 
143 
754 
+ 
+ 
9 + 
+ 
+ 
+ 
9 + 
0 + 
+ 
+ 
151 
5 
0.2 
30 
21 
11 
0.7 
0.2 
42 
45 
17 
75 
200 
422 
140 
1.4 
117 
81 
67 
4.4 
0.88 
133 
499 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
39 
6 
0.9 
12 
8 
5 
0.3 
0.06 
10 
23 
TABLE 4-6 
Aprobarbital in the intact rat. 
Pharmaookinetio data and parameters calculated from blood concentration curves. 
Exp. number 
Dose (mg/kg) 
Weight (g) 
Aj (mg/l) 
A 2 (mg/l) 
τ. (min) 
τ- (min) 
t, (min) 
к
 2 (ml/min.kg) 
к , (ml/min.kg) 
к , (ml/min) 
V 1 (ml/kg) 
V f (ml/kg) 
18 
75 
200 
117 
56 
1. 
206 
143 
195 
6 
1. 
431 
1290 
+ 
+ 
5 + 
+ 
+ 
+ 
+ 
3 + 
+ 
+ 
47 
4 
0.6 
54 
37 
50 
1 
0.3 
119 
104 
19 
56 
213 
689 
102 
0.8 
101 
70 
78 
5 
1.1 
71 
499 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
186 
12 
0.2 
37 
26 
9 
1 
0.3 
17 
63 
20 
37.5 
213 
86 + 
50 + 
0.9 + 
276 + 
191 + 
197 + 
2.7 + 
0.6 + 
276 + 
742 + 
19 
2 
0.5 
42 
29 
42 
0.5 
0.1 
40 
31 
21 
56.25 
213 
205 
45 
0.8 
246 
170 
240 
5.0 
1.1 
226 
1227 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
67 
2 
0.2 
40 
28 
17 
0.6 
0.1 
62 
58 
22 
60 
200 
350 
91 
+ 132 
+ 7 
0.9 + 0.3 
422 
292 
114 
+ 190 
+ 132 
+ 12 
1.5 + 0.6 
o.: 
136 
664 
Ì + 0.1 
+ 42 
+ 50 
TABLE 4-7 
Aprobarbital in the isolated perfused rat liver. 
Kinetic data and parameters calculated from blood concentration curves. 
Perf. No. 
Dose (ng) 
C 0 (mg/l) 
τ (min) 
t^ (min) 
V f (ml) 
k
el (ml/inin) 
7 
68 
316 
219 
103 
0, 
48 
+ 
+ 
+ 
+ 
36 + 
2 
88 
61 
4 
0,08 
49 
5 
55 
350 
242 
92 
0. 
+ 4 
+ 2.32 
+ 160 
+ 7 
3 + 0.2 
50 
5 
53 
230 
159 
95 
0. 
+ 
+ 
+ 
+ 
42 + 
2 
55 
38 
4 
0.08 
51 
5 
53 
553 
383 
94 
0. 
+ 
+ 
+ 
+ 
2 + 
3 
454 
314 
5 
0.1 
TAFLE 4-8 
Butobarbital in the isolated perfused rat liver. 
Kinetic data and parameters calculated from blood concentration curves. 
Perf. No. 
Dose (mg) 
C 0 (mg/l) 
τ (min) 
t, (min) 
V f (ml) 
к , (ml/min) 
8 
78 
171 
119 
102 
0. 
37 
+ 
+ 
+ 
+ 
60 + 
2 
14 
10 
3 
0.04 
52 
5 
47.9 + 
166 + 
115 + 
104 + 
0.60 + 
0.7 
11 
8 
3 
0.06 
53 
5 
50 
163 
113 
99 
0.6 
+ 4 
+ 47 
+ 32 
+ 14 
+ 0.2 
54 
5 
46.3 + 0.5 
185 + 8 
128 + 5 
108 + 2 
0.58 + 0.04 
55 
5 
54 
120 
83 
93 
0. 
+ 
+ 
+ 
+ 
7 + 
4 
19 
13 
10 
0.1 
56 
5 
47 
181 
125 
107 
0. 
+ 
+ 
+ 
+ 
59 + 
1 
17 
12 
4 
0.06 
^^к^с-с 
0=^=0 
1 I 
II 
0 
phénobarbital 
^ ¿ V c - c 
0=^=0 
N^N-C 
i 1 
II 
0 
mephobarbital 
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CHAPTER 5 
KINETICS OF ELIMINATION OF PHENOBARBITAL AND MEPHOBARBITAL 
IN THE INTACT RAT AND THE ISOLATED PERFUSED RAT LIVER 
Phénobarbital and mephobarbital are two representatives 
of the class of very long acting barbiturates (McArdle, 1971; 
Sharpless, 1970). These two compounds have similar structure, 
differing only in one methyl-group on one of the nitrogens of 
the pyrimidine ring. Because of their long lasting effect and 
their specific anticonvulsant properties in man, they are 
used as sedatives and antiepileptics. 
They also behave as long acting central depressants in 
other species where they also show specific anticonvulsant 
properties. They protect animals from artificially induced 
convulsions in doses that do not produce sedation or narcosis 
(Sharpless, 1970; Toman, 1970). 
In order to obtain information on the role of distribution 
and metabolism, the kinetics of mephobarbital and phénobarbital 
have been studied in the intact rat and in the isolated perfused 
liver of the rat. 
METHODS AND MATERIALS 
Experimental methode 
Male wistar rats were used in the intact rat and in the 
perfused liver experiments. Five animals were injected i.v. 
with phénobarbital in a dose that varied from 8.42 - 21 mg 
(42.1 - 105 mg/kg) and two animals were injected i.v. with 
12 - 15 mg (62.2 - 63.8 mg/kg) of mephobarbital. 
Blood samples were taken at regular intervals of time 
for determination of the drug content (see table 5-1 and table 
5-2). Pharmacokinetic parameters were calculated from the drug 
concentration in the blood as function of time following the 
administration (see chapter 1 and 2). 
The isolation and perfusion of the liver was done as 
described in chapter 2. In four perfusions, 10 mg of phéno-
barbital, and in an other four perfusions, б - 10 mg of mepho-
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F i g u r e 5 - 1 loo.o іго.о ічо.о leo.o leo.o no.o 
TIMF(MIN) 
Blood oonoentrati-on егвив time, following intravenoua 
administration of в odium Phénobarbital (IOS mg/kg of the 
free acid; rat number 26). The pointe represent individual 
experimental values, whereas the line is the best fit 
aooording to the computer program for a biexponential curve 
mentioned in chapter 2. 
Figure 5-2 so.o 
TIME (HIN) 
Blood concentration versus time, following intravenous 
administration of sodium Mephobarbital (62.2 mg/kg of the 
free acid; rat number 28). The points represent individual 
experimental values, whereas the line is the best fit 
aooording to the computer program for a biexponential 
curve mentioned in chapter 2. 
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barbital was added to the perfusion fluid. Samples of the 
perfusate were taken at regular time intervals for determi-
nation of the drug content (see table 5-3 and table 5-4). 
Kinetic parameters were calculated from the concentration of 
the drug in the perfusate as function of time after admini-
stration. 
Druga 
The free acids of phénobarbital and mephobarbital were 
dissolved in sterile water with an equimolecular amount of 
NaOH to a final concentration of 25 mg/ml. Therefore, the 
volume of liquid injected to each animal or added to the 
perfusion fluid was in the order of 0.5 ml, but always 
smaller than 1 ml. 
Analytical methode 
The drug content of the samples was determined by gas-
chromatography as was described in chapter 2. Nor-hexo-
barbital was used as internal standard. The column used was 
packed with 3% SE-30 and 1% carbowax 20M (terephtalic acid 
terminated) on Diatoport S 60/80 mesh. The oven temperature 
was 200° - 205° С 
RESULTS 
After i.v. injection the concentration of both compounds 
fell rapidly over a period of 5 minutes, whereafter it de­
creased more slowly over a period of at least 2 hours. This 
fall was more pronounced with mephobarbital as may be seen 
from two typical examples of the blood curve presented in 
figure 5-1 and figure 5-2. The curves of the blood concen­
tration as a function of time plotted on a semilogarithmic 
scale are essentially biphasic. The blood curve may therefore 
be described by two exponential terms according to the 
open two compartment kinetic model. The concentration of both 
barbiturates decreased in the first portion of the curve with 
a half-life of 0.2 - 2.7 minutes. In one of the rats, injected 
with phénobarbital (rat number 25), the initial fall was much 
less pronounced than in the others. The decrease in the blood-
concentration in the second phase of the curve corresponds to 
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a half-life of 5 - 11 hours for phénobarbital and 1.5 - 1.8 
hours for mephobarbital. From the blood curve for phénobar-
bital in rat number 23, it may be seen that the second 
exponential term remains in operation more than 20 hours 
after injection. See figure 5-3. It also may be seen that 
the distribution phase may be neglected in case of phéno-
barbital. On the other hand, mephobarbital is not a long 
acting barbiturate by itself and for this drug the distri-
bution phase is more important. 
2.1 
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Figure 5-3 
Blood о one ent rat ion versus time, following intravenous 
administration of sodium Phénobarbital (63.1 mg/kg of the 
free acid; rat number 23). The points represent individual 
experimental values, whereas the line is the best fit 
aooording to the computer program for a biexponential 
curve mentioned in chapter 2. Note that in the sample, 
taken 22 hours after ingestion, there is still a detectable 
amount of drug. 
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The pharmacokinetic constants from the animal experi­
ments are presented in table 5-5 and table 5-6. The value of 
the elimination clearance constant or к , of phénobarbital 
was 0.2 - 0.3 ml/min (mean = 0.25 ml/min) and of mepho-
barbital 1.2 - 1.8 ml/min (mean = 1.5 ml/min). When nor-
malized to the body weight, phénobarbital has an elimination 
clearance constant of 0.8 - 2.0 ml/min kg (mean = 1.3 ml/min 
kg) and mephobarbital of 5.1 - 8.8 ml/min kg (mean = 7 ml/min 
kg). There is a clear difference in the value of к ., indica­
ting that the more rapid elimination of mephobarbital, as 
compared to phénobarbital, is due to a difference in elimination. 
The clearance constant of distribution between the two 
compartments or k.« is 69.6 ml/min»kg for phénobarbital and 
168 ml/min kg for mephobarbital. The mean values of the 
volume of the central compartment (V.) and the fictive volume 
of distribution (Vf) for phénobarbital are 521 ml/kg and 947 
ml/kg respectively; the corresponding values for mephobarbital 
are 257 ml/kg and 977 ml/kg. 
In the liver perfusion experiments both barbiturates are 
cleared from the perfusate according to single compartment 
kinetics (see figure 5-4 and figure 5-5). Mephobarbital is 
eliminated more rapidly than phénobarbital. The metabolic 
clearance constant for phénobarbital is 0.3 - 0.4 ml/min 
(mean = 0.3 ml/min) and for mephobarbital is 0.4 - 0.9 ml/min 
(mean = 0.5 ml/min) (see table 5-7 and table 5-8). For both 
drugs the amount excreted in the bile was less than 10 pet of 
the total amount eliminated. The volume of distribution of 
both drugs in the perfusion apparatus was approximately equal 
to the volume of perfusate. The mean value for phénobarbital 
was 109 ml and for mephobarbital 97 ml. 
Since phénobarbital is supposed to be one major metabolite 
of mephobarbital, the presence of phénobarbital was checked in 
all the samples of the mephobarbital experiments (in vivo and 
in vitro). Only traces of phénobarbital were found in the last 
samples from both isolated liver and intact rat experiments. 
Metabolism to phénobarbital was not found to be of importance 
in these acute experiments. 
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Perfusion fluid вгвив time, following addition of sodium 
"Phénobarbital (10 mg of the free acid; experiment number 58), 
The pointe represent individual experimental values, whereas 
the line is the best fit according to the computer program 
for a mono-exponential curve mentioned in chapter 2. 
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Figure 5-5 flO.0 
TIME (MINUTES) 
Perfusion fluid versus time, following addition of sodium 
Mephobarbital (10 mg of the free acid; experiment number 62), 
The points represent individual experimental values, whereas 
the line is the best fit according to the computer program 
for a mono-exponential curve mentioned in chapter 2. 
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DISCUSSION 
The rate of elimination of phénobarbital differs from 
that of mephobarbital in the Wistar rat as can be seen from 
the value of the clearance constant of elimination of both 
barbiturates. Phénobarbital has а к . of 1.3 ml/min»kg and 
mephobarbital 7 ml/min*kg. In the isolated perfused rat liver 
there was also a difference between the rate of metabolism of 
phénobarbital and mephobarbital but this was less pronounced 
than in the animal experiments. The metabolic clearance 
constant of mephobarbital in the perfused rat liver was 
lower than that in the intact rat. The rats, used in these 
mephobarbital experiments, were much younger than those, used 
in the intact rat experiments. 
It has been reported that phénobarbital is eliminated by 
the kidneys in man (Myschetzky and Lassen, 1971), in the horse 
(Nicholson, 1968) and in the rat (Parke, 1971). The renal 
excretion of phénobarbital depends on the pH and flow of the 
urine. Unless the pH is kept alkaline and a high rate of 
urine flow is maintained, the amount eliminated is minimal 
(Bloomer and Maddock, 1971) . In the present experiments no 
attempt was made to alter the pH and/or urine flow, therefore, 
it seems probable that the renal excretion of phénobarbital 
was small. It may be concluded that in the conditions of the 
present experiment, phénobarbital was eliminated mainly by 
means of metabolism. 
The distribution of both barbiturates between the two 
compartments was very rapid (average k.- for phénobarbital 
= 69.6 ml/min·kg and for mephobarbital = 168 ml/min«kg), 
except in one experiment with phénobarbital, where k,- was 
equal to 19 ml/min*kg. In this experiment, number 25, the 
calculation of τ. was not accurate because there were not 
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enough points in the first part of the curve. 
The value of Vf indicates that both barbiturates were 
distributed over a volume equal to the body water (see 
Domínguez, 1950). 
The results of the present experiments agree with those 
reported by Butler (Butler e.a., 1952) in a similar investi-
gation with rats. Using the average data, given in this paper 
and assuming one compartment kinetics, an elimination clearance 
constant of 0.8 ml/min»kg for phénobarbital and 4.9 ml/min»kg 
for mephobarbital may be calculated. These volumes agree with 
those of our experiments. 
In other species there is also a difference in the rate 
of metabolism of phénobarbital and mephobarbital. In the dog, 
phénobarbital has clearance of elimination of 0.1 ml/min»kg 
and mephobarbital of 3.5 ml/min kg (Butler, 1952; Butler e.a., 
1952). 
The biological half-life of phénobarbital after oral 
administration in man is 87 hours (Lous, 1954). Since this 
half-life is much larger than the time constant of absorption, 
single compartment kinetics may be used. From the data of 
Lous, an elimination clearance constant of 0.08 ml/min·kg may 
be calculated. In the rat, the clearance constant is 1.3 ml/ 
min»kg. Therefore, the clearance in the rat is approximately 
16 times that in man. According to these data, phénobarbital 
is distributed in a volume of 587 ml/kg. This value is 
slightly smaller than the volume in the rat (947 ml/kg). 
The present results do not substantiate the importance 
of phénobarbital as a metabolite of mephobarbital or that 
mephobarbital acts by means of the phénobarbital supposedly 
produced. On the other hand, it has been reported that in the 
rat, half of the dose of mephobarbital is converted to phéno-
barbital (Butler e.a., 1952). Since they injected the drug 
intraperitoneally, the conditions for metabolism were perhaps 
more favorable than in the present experiments. 
Demethylation occurs also in man and dog (Butler, 1952). 
In the dog, after i.v. injection, approximately 100% of the 
dose is transformed to phénobarbital. In man, under chronic 
treatment with mephobarbital, a ratio of 0.2 - 0.3 
between the concentration of mephobarbital and phénobarbital 
was found. 
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From the present results and from the information 
available in the literature, it is clear that phénobarbital 
produces a very long lasting effect in most of the species. 
This long lasting effect is due to its very long half-life. 
On the other hand, mephobarbital has a short half-life in 
the rat and also in man. The long duration of action, 
produced by mephobarbital in man, may be attributed to the 
accumulation of its major metabolite, phénobarbital, following 
chronic administration of mephobarbital. 
SUMMARY 
The kinetics of distribution and elimination of phéno-
barbital and mephobarbital were studied in the intact rat and 
in the isolated perfused rat liver. In the rat, both drugs 
are eliminated according to two compartment kinetic. Mepho-
barbital was eliminated more rapidly than phénobarbital. 
Mephobarbital was not eliminated as rapid in the perfused 
liver as in the intact rat. It was concluded that in the 
actual conditions of the experiment, both barbiturates were 
eliminated mainly by metabolism in the liver. 
These results are compared with the kinetics of the same 
drugs in other species. In man, both barbiturates have a half-
life longer than in the rat. This difference is due mainly to 
a smaller elimination clearance constant in man. 
In the present experiments, only a small fraction of 
mephobarbital was found to be converted to phénobarbital. 
In other species this pathway of mephobarbital metabolism 
appears to play a more important role, especially upon 
repetitive administration. 
RESUMEN 
En el presente capítulo se describe la cinética de la , 
eliminación y distribución de los barbitûricos fenobarbital 
y metilfenobarbital (mefobarbital) en la rata y en el hígado 
de rata aislado y perfundido. Se construyeron curvas de la 
concentración en sangre en función del tiempo. Ambos barbitû-
ricos fueron eliminados en la rata de acuerdo a la cinética 
del modelo abierto de dos compartimientos y en el hígado de 
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rata aislado y perfundido de acuerdo a la cinética del modelo 
de un solo compartimiento. Se calcularon los parámetros corres-
pondientes a cada una de las drogas en la rata (tabla 5-5 y 
tabla 5-6) y en el hígado de rata aislado y perfundido 
(tabla 5-7 y tabla 5-8). En la rata mefobarbital es eliminado 
en forma más rápida que fenobarbital. Esta relación no fue 
encontrada en el hígado de rata aislado, en esta preparación 
mefobarbital no es eliminado tan rapidamente como en la rata. 
Los resultados obtenidos en estos experimentos fueron 
comparados con los resultados obtenidos en otras especies. 
En el hombre ambas drogas tienen una hemivida más larga que 
en la rata. Esta diferencia se debe principalmente a que la 
constante de aclaramiento total, normalizada en relación al 
peso, es mayor en la rata que en el hombre. 
No se confirmó la importancia de fenobarbital como 
metabolito de mefobarbital. Sólo una pequefla parte de este 
último aparece transformada en fenobarbital. Por el contrario, 
en otras especies incluido el hombre, esta forma de metabolismo 
juega un rol más importante que en la rata. 
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TABLE 5-1 
Mephobarbital in the intact rat. 
Experimental data in aase of i.V. injection of the sodium salt. 
Experiment 28 
Time (min) 
2.00 
3.00 
4.25 
6.50 
10.50 
15.50 
31.00 
36.00 
48.00 
Cone, (mg/1) 
65.0 
56.3 
51.4 
51.4 
46.6 
46.6 
40.4 
41.0 
35.9 
Experiment 29 
Time (min) 
3.0 
4.0 
11.0 
17.5 
21.5 
26.0 
32.5 
46.5 
Cone, (mg/1) 
94.8 
79.2 
75.7 
62.7 
65.0 
61.0 
58.2 
58.2 
95 
TABLE 5-2 
Phénobarbital in the intact rat. 
Experimental data in case of i.V. injection of the sodium salt. 
Exp. 23 
Time 
min. 
2 
4 
6 
15 
25 
51 
193 
237 
266 
322 
385 
1369 
Cone. 
mg/1. 
100.3 
89.6 
84.0 
96.0 
78.0 
80.0 
62.0 
63.4 
55.4 
52.8 
51.0 
13.9 
Exp. 24 
Time 
min. 
2.0 
3.0 
4.5 
86.0 
266.0 
377.0 
476.0 
Cone. 
mg/1. 
100.2 
89.1 
80.5 
58.3 
39.5 
44.0 
35.8 
Exp. 25 
Time 
min. 
2.5 
4.0 
98.0 
158.0 
414.0 
487.0 
539.0 
Cone. 
mg/1. 
96.4 
94.1 
57.2 
60.1 
40.2 
39.4 
35.9 
Exp. 26 
Time 
min. 
2.0 
4.0 
5.0 
9.5 
31.0 
70.0 
133.0 
199.0 
Cone. 
mg/1. 
290.0 
232.3 
232.3 
192.7 
174.2 
167.6 
163.0 
138.3 
Exp. 27 
Time 
min. 
1.0 
3.0 
6.0 
14.5 
74.5 
230.5 
300.5 
450.5 
Cone. 
mg/1. 
77.4 
57.4 
49.2 
46.2 
43.2 
29.2 
21.6 
20.0 
Perf. 
Time 
min. 
5 
10 
20 
40 
60 
80 
No. 64 
Cone. 
mg/l. 
73.7 
77.3 
72.8 
63.8 
59.7 
56.9 
Perf. 
Time 
min. 
5 
20 
40 
60 
80 
No. 62 
Cone. 
mg/l. 
106.4 
96.1 
66.5 
61.2 
55.0 
Perf. 
Time 
min. 
5 
10 
20 
60 
80 
No. 6 3 
Cone. 
mg/l. 
62.1 
44.4 
58.7 
45.1 
39.4 
Perf. 
Time 
min. 
5 
10 
20 
40 
60 
80 
No. 65 
Cone. 
mg/l. 
76.0 
71.7 
60.0 
58.9 
55.2 
50.8 
TABLE 5-4 
Phénobarbital in the isolated perfused rat liver. 
Experimental data after the addition of the sodium salt in the perfusion medium. 
Perf. No. 58 
Time 
min. 
5 
10 
20 
40 
60 
80 
Cone. 
mg/1. 
94.6 
93.4 
87.0 
80.7 
81.5 
77.4 
Perf. No. 59 
Time 
• min. 
5 
10 
20 
40 
60 
80 
Cone. 
mg/1. 
90.9 
91.3 
78.2 
71.2 
71.5 
67.0 
Perf. No. 61 
Time 
min. 
5 
10 
20 
40 
60 
70 
Cone. 
mg/1. 
90.6 
94.5 
81.9 
73.5 
71.6 
74.4 
Perf. No. 60 
Time 
min. 
5 
10 
20 
40 
60 
80 
Cone. 
mg/1. 
90.4 
89.7 
75.1 
75.8 
76.7 
71.5 
TABLE 5-5 
Mephobarbital in the intact rat. 
Pharmacokinetic data and parameters calculated from 
blood concentration curvee. 
Exp. number 
Dose (mg/kg) 
Weight (g) 
A 1 (mg/ml) 
A 2 (mg/ml) 
Tj^  (min) 
τ 2 (min) 
t, (min) 
k l 2 (ml/min. 
к , (ml/min. 
k
e l (ml/min) 
Vj (ml/kg) 
V f (ml/kg) 
kg) 
kg) 
28 
62,2 
200 
92 
52 
1,05 
134 
93 
254 
8,8 
1,8 
431 
1164 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
58 
1 
0, 
14 
10 
38 
38 
0, 
176 
33 
34 
1 
29 
63,8 
235 
682 
74 
0,88 
160 
111 
82 
5,1 
1,2 
84 
782 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
1744 
5 
0,65 
61 
42 
115 
1,5 
0,4 
193 
175 
98 
TABLE 5-6 
Phénobarbital in the intact rat. 
Pharmacokinetic data and parameters calculated from blood concentration curves following 
intravenous injection. 
Experiment 23 
number 
Dose (mg/kg) 
Weight (g) 
Aj (mg/ml) 
A2 (mg/ml) 
τ. (min) 
τ 2 (min) 
t, (min) 
k 1 2 (mi/min.kg) 
к , (ml/min.kg) 
к . (ml/min) 
V 1 (ml/kg) 
V f (ml/kg) 
63.1 
200 
50 + 57 
83.9 + 2.2 
1.8 + 1.6 
753 + 31 
522 + 21 
98 + 110 
0.99+ 0.03 
0.20+ 0.006 
468 + 200 
750 + 20 
24 
68 
60 
3. 
913 
632 
90 
1. 
0. 
641 
1355 
82.05 
195 
+ 39 
+ 7 
7 + 2.8 
+ 310 
+ 214 
+ 64 
5 + 0.34 
29+ 0.06 
+ 196 
+ 166 
25 
36 
67 
14 
872 
604 
19 
1. 
0. 
788 
192 
81.21 
197 
+ 21 
+ 4 
+ 33 
+ 107 
+ 74 
+ 51 
38+ 0.11 
27+ 0.20 
+ 159 
+ 68 
26 
105 
200 
191 + 37 
185 + 6 
3.3 + 0.7 
759 + 159 
526 + 110 
43 + 9 
0.75+ 0.13 
0.15+ '.03 
280 + 29 
564 + 20 
27 
51 
48 
2 
459 
318 
117 
1. 
0. 
426 
876 
42. 
190 
+ 
+ 
+ 
+ 
+ 
+ 
9 + 
36+ 
+ 
+ 
1 
21 
3 
1 
58 
40 
62 
0.2 
0.03 
98 
60 
TABLE 5-7 
Phénobarbital in the isolated perfueed rat liver. 
Kinetic data and parameters calculated from blood concentration 
curvee. 
Perfusion number 
Dose (mg) 
Co (mg/1) 
τ (min) 
t, (min) 
V f (ml) 
к , (ml/min) 
94 
385 
267 
107 
0. 
58 
10 
±
 2 
±
 7 3 
±
 5 1 
± 2 
28+ 0.04 
59 
90 
248 
172 
112 
0. 
10 
+ 4 
±
 5 6 
±
 3 9 
+ 5 
46+ 0.08 
60 
87 
383 
266 
115 
0. 
10 
+ 4 
+ 150 
+ 104 
+ 5 
3 + 0.1 
61 
10 
92 + 4 
259 + 69 
179 + 48 
109 + 5 
0.4+ 0.1 
TABLE 5-8 
Mephobarbital in the isolated perfused rat liver. 
Kinetic data and parameters calculated from blood concentration 
curves. 
Perfusion number 
Dose (mg) 
Co (mg/1) 
τ (min) 
t, (min) 
V f (ml) 
к . (ml/min) 
108 
108 
75 
92 
0. 
62 
10 
+ 8 
+ 18 
+ 13 
+ 7 
9 + 0.1 
63 
55 
261 
181 
109 
0. 
6 
+ 6 
+ 161 
+ 111 
+ 12 
4 + 0.2 
64 
77 
245 
170 
90 
0. 
7 
+ 2 
+ 30 
+ 21 
+ 2 
36+ 0.04 
65 
73 
211 
147 
97 
0. 
7 
+ 3 
+ 45 
+ 31 
+ 4 
46+ 0.08 
100 

CHAPTER б 
GENERAL DISCUSSION 
DISCUSSION OF METHODS 
The rate of metabolism of the lipidsoluble drugs in the 
liver has been studied by measuring the metabolic capacity 
of in vitro preparations or the rate of elimination of such 
druas in vivo. For the study of drug metabolism different 
kinds of biochemical preparations have been described. They 
are: liver slices, liver homogenates, microsomal preparations 
and the isolated perfused liver (Shideman, 1952; Gram e.a., 
1970; Fujimoto e.a., 1959). This last technique was preferred 
to all others because it was desired to obtain information 
about the time course of the drug metabolism and be able to 
extrapolate to the in vivo conditions. With the other bio­
chemical techniques, it is not possible to have this kind of 
information, since cofactors have to be added which influence 
the metabolic capacity of the system. Within reasonable limits, 
it is possible to assume that the conditions in the perfused 
liver resemble the normal in vivo conditions. The principal 
differences between the perfused liver and the biochemical in 
vitro preparations is that the structure of the liver is not 
destroyed and its architecture is almost intact. In this way, 
many factors that play an important role in the whole animal, 
like diffusion from the blood to the liver, are also present. 
Obviously the blood flow in the perfused liver has to be of 
the same order of magnitude as in the intact rat. 
Nevertheless, some of the other in vitro preparations 
are valuable tools in the investigation of the mechanisms 
governing the drug metabolism. This holds true especially in 
the case of the microsomal preparation, but the results ob­
tained in this way are difficult to extrapolate to the in 
vivo conditions. 
The isolated perfused rat liver has been used in the study 
of the kinetics of metabolism (von Bahr e.a., 1970; Baggiolini 
e.a., 1969) and excretion in the bile (Meyer-Brunot and Keberle, 
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1968; Meijer and Weilerina, 1970) of different kinds of drugs, 
Many investigators have perfused the liver with rat blood. In 
one case (Nagashima e.a., 1968), the perfusion medium was a 
mixture of human plasma and rat cells. Some other researchers 
(Abskagen and Rietbrock, 1969; Schimassek, 1962) have used a 
semisynthetic medium similar to the one used here and always 
have obtained similar performances as with rat blood. 
As it appears from the results in the present experiments, 
the liver has shown a similar activity in the isolated system 
and in the intact rat. This can be clearly seen with the drugs 
known to be eliminated by metabolism in the liver like hexo-
barbital and pentobarbital. It can be said that in spite of the 
fact that a semisynthetic perfusion medium was used instead of 
whole blood, the liver was not significantly affected during 
the time that lasted the experiences. This holds true at least 
for the drug metabolizing system. 
In the in vivo experiments the interest was focused on the 
kinetics of elimination and distribution and on seeing how the 
one is influenced by the other. In the in vitro experiments 
the distribution over the body was avoided by eliminating the 
rest of the tissues. In the animal and perfusion experiments 
the same kind of animals were used in order to make a correla-
tion possible. Two possibilities were faced when developing the 
methods of the intact animal trials: group or single animal 
experiments. 
Group experiments are those where a large number of 
animals are injected at the same time, whereafter at regular 
intervals, small groups are killed and the drug concentration 
determined in the total blood of each animal (von Bahr e.a., 
1970); from these values a blood curve is made. 
Single animal experiments are those ones carried on like 
in the present investigation where the blood curve is obtained 
from the same subject. The group experiments have the dis-
advantage of needing a high number of animals in order to get 
enough points for the blood curve, and even using a great 
number of animals it is difficult to manage to get enough points 
from the first part of the curve. Another factor that obscures 
the results is the inter-animal variation. With regard to this 
point, the question arises what an "average" rat is and how to 
imagine a "pooled" rat. 
The use of the techniques of gas-liquid chromatography 
with its somehow high sensitivity have allowed the use of 
small quantities of blood for the drug analysis. In this way 
it was possible to carry out the experiment using one rat 
for each curve. According to experiments done in this 
laboratory it seems that the repeated blood sampling of the 
rat by orbital puncture has no effect in the drug metabo-
lizing system, but only a limited number of samples can be 
taken per day. 
One limitation of the method used was that the drug 
concentration was measured in the whole blood and not in 
plasma or plasma water. These limitations were imposed by the 
size of the sample. They may be solved in the future if a 
more sensitive technique is used or if less samples with a 
bigger volume are taken. Nevertheless, the results obtained 
may be of value to show some aspects of the kinetics of the 
different drugs investigated. 
DISCUSSION OF RESULTS 
The drugs used in the present investigation are represen-
tative of the different barbiturates used in clinic and in-
vestigation. The rate of elimination is the main difference 
found between the drugs studied. According to the rate of 
elimination in the animal, they can be classified in decreasing 
order as follows: hexobarbital > pentobarbital > mephobarbital 
> butobarbltal and aprobarbital > phénobarbital. In figure 6-1 
the values of the к ,'s corresponding to each barbiturate are 
graphically displayed. When the rate of elimination in the 
perfused liver is considered, different order is found. Here 
the drugs can be classified in descending order as follows: 
hexobarbital > pentobarbital > mephobarbital and butobarbital 
> phénobarbital and aprobarbital. The difference of results of 
aprobarbital in the animal and in the perfused liver may be 
explained by the presence of another way of elimination apart 
from the liver. It seems probable that this other route is the 
urine. 
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Graphical display of the values of the clearance constant 
of distribution (k.„)t volume of the central compartment 
and fictive volume of distribution (V-) found for the six 
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cate the experiment in which the constant was calculated. 
See further comments in the text. 
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The two barbiturates with a significant difference in 
the rate of elimination of both preparations were apro-
barbital and mephobarbital. Aprobarbital is known to be 
eliminated unchanged in the urine (Lous, 1954). In the case 
of mephobarbital, the rats used in the perfusion experiments 
were smaller than those used in the intact rat experiments. 
On the other hand, phénobarbital, known to be eliminated by 
the kidneys, apparently was not eliminated to a great extent 
by this route, because it was cleared at the same rate in the 
perfused liver and the intact rat. 
All the other drugs used were eliminated mainly by the 
liver. The possibilities for these druos of being eliminated 
by the kidneys are minimal because of their lipid solubility. 
It appears to be a correlation between the rate of 
metabolism and the degree of lipid solubility as it is ex-
pressed by the partition coefficient chloroform/water. This 
relation can be seen in table 6-1. Here are shown the values 
of pK 's, partition coefficient (chloroform/water), percentaae 
of drug undissociated at pH 7.4, and clearance constant of 
elimination and metabolism. Some of these values are oraphi-
cally displayed in figure 6-1. Mephobarbital does not fit in 
with the previous correlation. It has a higher partition co-
efficient than pentobarbital, but the value of its metabolic 
clearance constant is lower than the one of pentobarbital. 
On the other hand, it is interesting to note that when 
the partition coefficient is lower, there is a greater possi-
bility of beina excreted by the kidneys, as is the case for 
aprobarbital in addition to barbital, known to be eliminated 
almost completely by the kidneys, which has a true partition 
coefficient chloroform/water equal to 0.72. 
Regardless of the differences in the deoree of lipid 
solubility, the distribution pattern of the six drugs studied 
was similar. In figure 6-2 the distribution of the values of 
V , V- and k12 for the different drugs and experiments are 
oraphically shown. The spread of the values of V and k,- may 
be due to inter-individual variations and also to the error 
made in the calculation of these parameters. It appears that 
there was no correlation between these parameters and the 
lipid solubility and the pK . 
a. 
There was also no correlation between the fictive volume 
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of distribution and the physico-chemical constant. From the 
values obtained in the experiments it can be said that the 
barbiturates investigated have a fictive volume of distri-
bution approximately equal to the body water (Dominguez, 1950). 
One important question that always arises when investi-
gating with laboratory animals is, whether the results obtained 
can be extrapolated to man and other species. Because of this 
reason it is of real interest to compare the results obtained 
in the present investigation with rats to those obtained with 
other animals and especially with man. 
One important difference is that the rate of elimination 
of the barbiturates studied are not equal to the rates of eli-
mination in other species. This difference can be clearly seen 
when comparing the rates of elimination in the rat and those 
obtained in man. As it was said in previous chapters, the rate 
of elimination in the rat was always more rapid than in man. 
When the kinetic behaviour of the drug in the rat was 
compared with the kinetic behaviour in man, the principal 
difference found was the value of the metabolic clearance con-
stant. The other parameter known in man, the fictive volume of 
distribution, has a similar value in both species and is 
approximately equal to the value of the body water. In a paper 
about the volume of distribution, Dominguez (Dominguez, 1950) 
gives the volume of distribution of different substances. 
There, it can be seen that this parameter (when expressed as 
a fraction of the body weight) for each substance is very 
similar in different species. 
If the elimination clearance constant is the parameter 
compared, a big difference is found. As it was said in 
chapter 1, the relative weight (if expressed as a fraction 
of the body weight) of the liver in small animals is bigger 
than the liver in bigger animals. 
The weight of the liver in man is 25.1 g/kg and in the 
rat 33.5 g/kg (Spector, 1956). If the difference of activity 
in the liver is due only to its weight, it can be expected 
that the ratio of the liver weight of man/rat be similar to 
the ratio of the metabolic clearance constant in man and rat. 
The ratio man/rat of the liver weights is 0.8 and the 
correspondent ratio of the metabolic clearance constants is 
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0.06 for phénobarbital, 0.07 for aprobarbital and 0.1 for 
butobarbital. Therefore, it can be said that apparently 
there is no direct relation between the clearance constant 
and the weight of the liver. 
Another factor that may be responsible for the differ-
ence in the metabolic clearance constant is the activity of 
the drua metabolizing enzymes. The in vitro metabolism (micro-
somes) of hexobarbital occurs at different rates in mouse, 
rabbit, rat and dog (Quinn e.a., 1958); thiopental, in similar 
conditions is degradated at different rates in rat and calf 
(Sharma e.a., 1970). The difference in the enzyme activity may 
be due either to the content or to the Quality of the enzyme. 
In the examples, aiven above, the enzyme activity is expressed 
in mg/g.h and no information is given about V and К . 
max m 
Therefore, it is not possible to know the factor responsible 
for the difference. 
Another parameter that must also be considered in the 
present discussion is the plasma flow through the liver. It 
regulates the delivery of the drug to the oraan. It becomes 
more important when the rate of metabolism is very rapid (see 
chapter 1), but when it is lower its influence is negligible. 
When normalized to the body weight, the flow in the rat is 
laraer than in man (14.3 ml/min.kg in man (van Rossum, 1970) 
and 47 ml/min.kg in the rat, if the clearance constant of 
hexobarbital is assumed to be equal to the plasma flow). On 
the other hand, the plasma flow is also an important factor 
for the regulation of the different liver functions. Differ­
ences in the blood flow may produce functional alterations in 
the liver (Brauer, 1963). The plasma flow as a fraction of the 
liver weight is 1.4 ml/min.g in the rat and 0.57 ml/min.g in 
man. Therefore, differences may be expected in the functioning 
of the liver in the rat and man. 
Many other, unknown factors may be important in determining 
species differences in pharmacokinetics. The results presented 
here and those available in literature are not enough to allow 
any definite conclusion. Further investigation is needed in 
relation to this problem. A careful study of the pharmaco­
kinetics of different drugs in animals and man will allow the 
researcher to predict the kinetic behaviour of a new drug in man. 
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SUMMARY 
In the first part of this chapter are discussed the 
methods used in this investigation. The isolated perfused rat 
liver is compared with some other biochemical techniques used 
for studying the rate of drug metabolism. 
The technique of the intact rat experiments used here, 
is compared with another method used in other investigations. 
The gas-chromatographic determination of the barbiturates 
made it possible to use one rat for each blood curve. 
In the discussion of the results, the clearance constants 
of elimination and of metabolism of the drug used are compared. 
It appears to exist a certain correlation between the rate of 
metabolism and the degree of lipid solubility of the barbitu-
rates used. 
On the other hand, apparently there is no correlation 
between the lipid solubility and the parameters describing the 
distribution of the drug over the body. 
The differences found in the rate of drug metabolism in 
rat and man are discussed. For this purpose the relative weight 
of the liver, the plasma flow through the liver as a fraction 
of the body weight and of the liver weight, and the enzymatic 
activity of the liver in rat and man, are compared with the 
metabolic clearance constant of some drugs in both species. 
RESUMEN 
En la primera parte de este capitulo se comentan los 
métodos usados en esta investigación. 
Se compara al hígado de rata aislado y perfundido con 
otras preparaciones bioquímicas empleadas también en el 
estudio del metabolismo de las drogas. 
Se comparo también el método usado aquí para calcular 
las constantes farmacocinéticas en la rata con los usados 
por otros investigadores. 
La cromatografía de gases permite usar muestras de 
sangre pequeñas. Debido a esto se pudo construir una curva 
de la concentración en sanare de las droaas, usando una sola 
rata para cada curva. 
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En la discusión de los resultados se comparan las 
constantes total y metabòlica de aclaramiento. Se puede 
decir que hay cierta correlación entre la constante meta-
bòlica de aclaramiento y la liposolubilidad de los barbi-
túricos. 
Por otra parte, aparentemente no hay una relación di-
recta entre la liposolubilidad y los parámetros que des-
criben la distribución de la drooa en el organismo. 
Se discuten las diferencias que existen entre la 
velocidad de eliminación de una droaa en el hombre y la 
rata. El peso del hígado, la actividad enzimàtica de éste, 
el flujo sanguíneo a través del hígado expresado como 
fracción del peso total y como fracción del peso del hígado, 
fueron comparados con las constantes metabólicas de aclara-
miento de la rata y otras especies. En el futuro, cuando se 
profundice la investigación farmacocinética, quizás sea 
posible predecir el movimiento de una nueva droga en el hombre. 
TABLE 6-1 
Physical constants and total and apparent methabolio clearance 
of some barbiturates in the rat. 
Partition 
Coefficient 
CHCI3/OH2 
Hexobarbital 
Pentobarbital 
Mephobarbital 
Butobarbital 
Phénobarbital 
Aprobarbital 
129(2) 
23.4(1) 
95.5(2) 
15.5(1) 
4.4(2) 
3.4(1) 
PKa 
8.3(2) 
8.0(1) 
7.7(2) 
7.8(1) 
7.4(2) 
7.9(1) 
Pet free 
acid in 
pH 7.4 
89 
80 
65 
73 
49 
75 
mean к . 
ml/minei 
9.9 
2.7 
1.5 
0.9 
0.25 
0.9 
mean к 
ml/minm 
9.8 
2.3 
0.6 
0.6 
0.3 
0.3 
(1) from Yih, 1970 
(2) from Kakemi e . a . , 1967 
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STELLINGEN 
I 
The suqoestion of von Bahr et al. (1970) that differences 
In the degree of protein binding may be a relevant factor in 
the creation of the observed differences in the half-lives of 
some drugs as determined in the isolated perfused rat liver 
and in the intact rat respectively, is contradicted by the 
experimental data published by these authors: 
von Bahr et al.: European J. Pharmacol. £, 99 (1970) 
Thie thesie 
II 
The use of oral delayed action cannot be recommended when 
the druo has a hepatic metabolic clearance constant which is 
in the same order of the hepatic blood flow. 
Ill 
The experiments of Kaiser et al. (1969) on the metabolism 
of pentobarbital have little relevance, since the isolated 
perfused rat liver used was exposed to a pentobarbital concen-
tration which is incompatible with life. 
Kaleer3 S.C. et al.: J. Pharm. Exp. Ther. 170, 14S (1969) 
IV 
The pharmacokinetic parameters calculated, using blood 
curves from grouped animal experiments, are less reliable than 
the ones calculated from individual animal experiments. 
Butler, T.C. et al.: J. Pharm. Exp. Ther. 106, 364 (19S2) 
Kato, R. and A. Takanaka: Jap. J. Pharmacol. 17_, 208 (1967) 
This thesie 
ν 
Bagqiolini et al. (1969) wrongly expressed the time 
course of the elimination of procarbazine by the isolated 
perfused rat liver in terms of weight per time. 
Baggiolini, M. et al.: Bìoahem. Pharmacol. 18, 2187 (1969) 
VI 
From the series of compounds described by Fischer and 
von Mering in 1903, the authors selected barbital as the most 
suitable hypnotic agent. However, on the base of the properties 
of the compounds as described in the publication in question, 
the drug methyl-propyl-barbituric acid would have been a better 
choise. 
Fieaher, E. and J. von Mering: Therapie d. Gegenw. 443 97 
(1903) 
VII 
The expression "vida media" commonly used in the Spanish 
language to indicate the parameter half-life, is incorrect and 
leads to misunderstanding. 
VIII 
A clear example of the effects that may be produced by the 
introduction of a new intoxicant or inebriant among people not 
used to it, is the effects of the introduction of strong 
distilled alcoholic drinks on the indigenous population of the 
American continent. 
IX 
An underdeveloped country cannot achieve real progress if 
it only relies on foreign science and technology. 


